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ABSTRACT

Gregoriades, Jeannine Marie Crum. Ph.D., Biomedical Sciences PhD Program, Wright State
University, 2017. Functions of the apical Na+/K+/2Cl- Cotransporter 1 in choroid plexus
epithelial cells.

Choroid plexus epithelial cells (CPECs) secrete cerebrospinal fluid (CSF) and regulate its
electrolyte composition. CPECs express both the Na+/K+ ATPase and the Na+/K+/2Clcotransporter 1 (NKCC1) on their apical membrane (CSF facing), deviating from the typical
basolateral membrane location in chloride secretory epithelia. Given this unusual location
of NKCC1 and the unknown intracellular Na+ and Cl- concentrations of CPECs, the
cotransporter function in these cells is not understood. Further, the direction of net ion and
associated water fluxes mediated by NKCC1 under basal physiological conditions in CPECs
is controversial. Determining the direction of NKCC1- mediated fluxes is critical to
understanding the function of this cotransporter in CPECs. If NKCC1 works in the net efflux
mode, it may be involved in CSF secretion as suggested by some investigators. Conversely, if
NKCC1 works in the net influx mode, as it does in the basolateral membrane of other
chloride secreting epithelia, then it would have an absorptive function in CPECs and could
be involved in CSF K+ regulation, as we and others propose. NKCC1-mediated ion and water
fluxes are tightly linked; thus, their direction is inferred by measuring cell water volume
(CWV) changes in calcein-loaded CPECs following NKCC1 inactivation. Both genetic and
pharmacological inactivation of NKCC1 produces CPEC shrinkage of ~16 %, due to
unbalanced solute and water effluxes. [Na+]i and [Cl-]i measurements using the fluorescent
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indicator dyes ANG-2 and MQAE show that [Na+]i = 8.4 ± 1.0 mM and [Cl-]i = 62.1 ± 3.5 mM.
NKCC1 -/- CPECs have ~ 50% less [Cl-]i than WT. WT CPECs are exquisitely sensitive to
isosmotic changes in [K+]o (± 2 mM), as shown by CWV responses. CPECs of NKCC1-/mouse lose the response to [K+]o.. These results suggest that under basal conditions, NKCC1
is constitutively active and works in the inward mode near its thermodynamic equilibrium
in CPECS. We propose NKCC1 has absorptive functions and contributes to the maintenance
of normal and constant CWV. The Km for [K+]o and the thermodynamic forces driving
NKCC1 transport in CPECs suggest that it functions as a sensor and regulator of CSF [K+].
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Chapter 1: Background
Choroid plexus

The choroid plexus epithelium makes up the blood-cerebrospinal fluidbarrier, and consists of a monolayer of cuboidal epithelial cells bound together by
tight-junctions, surrounding highly-fenestrated capillaries that maintain an
impressive blood-flow of 3 –5 ml/ min/ gram (Damkier, Brown, & Praetorius, 2010;
Johanson, Stopa, & McMillan, 2011). On the apical membrane, choroid plexus
epithelial cells (CPECs) have beating cilia that protrude from the densely packed
microvilli surface, and function to agitate unstirred layers and facilitate
cerebrospinal fluid (CSF) circulation (Redzic & Segal, 2004). A convection current/
flow of CSF is generated by the beating cilia on CPECs and directs the CSF from the
lateral ventricles through the third and fourth ventricles, and around the spinal cord
and brain (Bulat & Klarica, 2011; Damkier et al., 2010). Floating in the brain
ventricles, the choroid plexus epithelium is continuous with the ependymal cells
lining the ventricles. It has several functions, many which are still under
investigation, though the most common function ascribed to the choroid plexus is
the ability to secrete CSF (Praetorius & Damkier, 2017; Spector, Keep, Robert
Snodgrass, Smith, & Johanson, 2015). CSF flows through the ventricles and around
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the brain and spinal cord, freely diffusing with the interstitial fluid (ISF) that fills the
extracellular spaces between neurons and glia. Ependymal cells that line the
cerebral ventricles are very permeable and allow free diffusion of small solutes
between ventricular CSF and brain ISF (Johanson et al., 2008; Johanson et al., 2011).
CPECs maintain a net efflux of Na+, Cl-, HCO3-, and H2O into the ventricles, while
simultaneously mediating a net influx of K+ from the CSF to blood (Brown, Davies,
Speake, & Millar, 2004; Damkier et al., 2010; Husted & Reed, 1976; Wright, 1978).

Constantly flowing CSF through the ventricles provides a sink for excess
extracellular ions (e.g., K+), neurotransmitters, metabolites, and other waste
products to diffuse into for removal by the choroid plexus (Brown et al., 2004). The
choroid plexus absorbs these waste products from the CSF and transfers them to the
plasma for later processing by the kidney (Johanson et al., 2011). This leads to the
choroid plexus being coined “the kidney of the brain” (Spector & Johanson, 1989).
Another similarity between the kidney and the choroid plexus is the apical
expression of a Na+/ K+/ 2Cl- Cotransporter (NKCC), in the pattern of a Cl- absorptive
epithelium (Alvarez-Leefmans, 2012; Russell, 2000; Spector & Johanson, 1989). In
Cl- absorbing epithelia (Figure 1.1B), such as in the thick ascending limb of Henle’s
loop and the macula densa of the kidney, NKCC2 is expressed on the apical
membrane and Na+/K+ ATPase (NKATP) remains on the basolateral membrane
(Alvarez-Leefmans, 2012). However, the choroid plexus is considered a chloride
secreting epithelium, producing CSF with a higher chloride concentration ([Cl-])
than that of the plasma (Alvarez-Leefmans, 2012; Brown et al., 2004; Wright, 1978).
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In Cl- secreting epithelia (Figure 1.1A), such as those found in exocrine glands (e.g.,
salivary glands or tracheal epithelium) or the ciliary body of the eye, NKATP and
NKCC1 are expressed in the basolateral membrane where NKCC1 functions as a Clloader (Alvarez-Leefmans, 2012; Hamann, Herrera-Perez, Zeuthen, & AlvarezLeefmans, 2010). It should be noted that in both Cl- secreting and Cl- absorbing
epithelia, NKCC-mediated cotransport occurs in the net influx mode (Figure 1.1A, B).
However, in CPECs the direction of net ion fluxes mediated by NKCC1 is uncertain
(Figure 1.1C). It has been hypothesized that the cotransporter works near its
thermodynamic equilibrium given the low CSF [K+], approximately 2.9 –3.0 mM,
which may favor the cotransporter to fluctuate between inward-directed and
outward-directed modes (Keep, Xiang, & Betz, 1994). The uncertainty regarding
NKCC1 cotransport direction is the result of its unusual apical location for a Clsecreting epithelium, combined with conflicting reports of the [Na+]i (Amin, Reza,
Wang, & Leenen, 2009; Johanson & Murphy, 1990; Keep et al., 1994; Saito & Wright,
1987; Smith & Johanson, 1985; Zeuthen, 1987). Determining the direction of
NKCC1- mediated fluxes is critical to understanding the function of this
cotransporter in CPECs. If NKCC1 works in the net efflux mode, it may be involved
in CSF secretion. Conversely, if NKCC1 works in the net influx mode, as it does in the
basolateral membrane of other chloride secreting epithelia, then it would have an
absorptive function in CPECs and could be involved in cell water volume (CWV)
maintenance and CSF K+ regulation.

3

Figure 1.1: Basic mechanisms for active Cl- secretion and absorption in Cl- transporting epithelia. Cl- secreting
epithelia (A) have NKCC1 and NKATP on the basolateral membrane. K+ is recycled on the basolateral membrane through
K+ channels, and Na+ is transported out through NKATP activity on the basolateral membrane. NKCC1 maintains [Cl-]i
above electrochemical equilibrium, and Cl- secretion occurs through apical Cl- channels. Cl- absorbing epithelia (B) have
NKCC2 on the apical membrane and NKATP on the basolateral membrane. K+ is recycled on the apical membrane
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through K+ channels, and Na+ is transported out through NKATP activity on the basolateral membrane. Cl- efflux occurs
through basolateral Cl- channels. CPECs (C) have NKCC1, NKATP, and Cl- and K+ channels on the apical membrane,
which leads to the debate over the function of NKCC1 in these cells.

5

Importance of CSF potassium regulation

Maintaining a low CSF [K+] is critical for normal brain function. Under normal
conditions the CNS [K+] is approximately 2.9 mM, lower than the plasma [K+] of ~4.7
mM (Damkier et al., 2010; Somjen, 2002). The CSF [K+] remains constant through
the combination of glia and CP K+ absorption (Bradbury & Kleeman, 1967; Jones &
Keep, 1987; Keep & Xiang, 1995; Keep et al., 1994; Stummer, Keep, & Betz, 1994).
Glial cells utilize NKCC1 to absorb K+ from the small extracellular spaces around
neurons and transport it away to either the blood vessels or the CSF in the ventricles
(Kahle et al., 2009; Lu et al., 2006). Once K+ enters into the CSF filled ventricles (in
these experiments, a portion of the CP of the lateral ventricles was isolated using an
oil filled chamber. A small amount of artificial CSF, with varying [K+], was added to
the isolation chamber and freshly secreted fluid from the CP was collected from
under the oil of the chamber.), any excess is removed by CPECs (Ames, Higashi, &
Nesbett, 1965; Cserr, 1965; Husted & Reed, 1976). The apical membrane of CPECs is
considerably more permeable to K+ than the basolateral membrane (Keep & Xiang,
1995; Zeuthen & Wright, 1981), and CPECs respond to a rise in CSF [K+] by
increasing their apical K+ uptake (Parmelee, Bairamian, & Johanson, 1991). Early
studies proposed that CPECs regulate the [K+] of freshly secreted CSF in response to
the [K+] directly around them (Ames et al., 1965; Husted & Reed, 1976). CPECs are
very responsive to high CSF [K+] by reducing the amount [K+] secreted, however
lowering CSF [K+] elicits only a slight increase in the [K+] secreted (Ames et al.,
1965; Husted & Reed, 1976). Moreover, CPECs maintain the CSF K+ homeostasis
6

even with severe changes in plasma [K+]: CSF [K+] increases only ~0.2 mM when
plasma concentrations of K+ increased up to 9 mM, and CSF [K+] decreases only ~0.5
mM when plasma [K+] is reduced to almost 2 mM (Ames et al., 1965; Bekaert &
Demeester, 1954; Cserr, 1965; Husted & Reed, 1976). Both NKATP and NKCC1 can
uptake CSF K+ on the apical membrane of CPECs, but NKCC1 is more capable of CSF
K+ sensing and regulation because, unlike NKATP, NKCC1 can reverse its direction of
transport under physiological conditions (Russell, 2000). The low CSF [K+] is often
attributed to the presence of NKATP on the apical membrane of CPECs (Redzic &
Segal, 2004). The NKATP subunits expressed in CPECs are α1b1 and α1b2 that have
a Km for K+ of 0.92 and 1.16 mM, respectively (Brown et al., 2004; Crambert et al.,
2000; Watts, Sanchez-Watts, Emanuel, & Levenson, 1991). This means that while
NKATPα1b1/b2 has a high affinity for [K+]o, the pump is working close to maximal
capacity, or Vmax , for normal external [K+] in CPECs. Additionally, NKATP alone
cannot account for the K+-induced cell swelling observed in glia and CPECs since the
pump does not transport anions (Macaulay & Zeuthen, 2012; Wu, Delpire, Hebert, &
Strange, 1998). In comparison, human NKCC1 has a Km for external K+ of ~2.7 mM
(Payne & Forbush, 1995). NKCC1’s lower affinity and higher capacity for [K+]o
bestows the cotransporter with the ability to sense and respond to changes in CSF
K+ .

NKCC1

The NKCC1 cotransporter is a member of the larger Slc12a cation-chloride
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cotransporter family (Alvarez-Leefmans, 2012). NKCC1 has a predicted 12transmembrane domain structure, cotransports Na+, K+, and Cl- ions across the
plasma membrane with a stoichiometry of 1Na+: 1K+: 2Cl- , and is inhibited by the
loop-diuretic bumetanide (Alvarez-Leefmans, 2012; Russell, 2000). NKCC1 is a
secondary active transporter, meaning that it depends indirectly on the energy
generated from ATP by using the sum of chemical potential gradients of 2Cl-, K+, and
Na+ that is established by NKATP (Alvarez-Leefmans, 2012). The cotransport of two
cations (Na+ and K+) and two anions (2x Cl-) per cycle is electroneutral and coupled,
thus all four ions must first bind to the cotransporter on the uptake side in order for
NKCC1 to transport across the membrane (Alvarez-Leefmans, 2012; Lytle,
McManus, & Haas, 1998). NKCC1 is ubiquitously expressed in most cell types and
cotransports both ions and water (Hamann, Herrera-Perez, Bundgaard, AlvarezLeefmans, & Zeuthen, 2005; Hamann et al., 2010; Macaulay & Zeuthen, 2012;
Zeuthen & Macaulay, 2012).

Activation of the NKCC1 cotransporter occurs through the phosphorylation
of serine/threonine residues located on the amino-terminal (Gagnon, England, &
Delpire, 2007). The cotransporter is phosphorylated by the WNKs/SPAK/OSR1
pathway: WNKs (with no lysine (K) kinases) are a family of kinases (WNK1-WNK4)
activated by phosphorylation in response to osmotic stress, and then WNKs
phosphorylate and activate SPAK (SPS1-related proline/alanine-rich kinase) and
OSR1 (oxidative stress-response kinase 1), which will phosphorylate and activate
NKCC1 (Delpire & Gagnon, 2006; Gagnon, England, & Delpire, 2006; Grimm et al.,
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2012; Thastrup et al., 2012). Increased phosphorylation of NKCC1 occurs in
response to a drop in [Cl-]i and to cell shrinkage, when NKCC1-mediate ion and
associated water fluxes are needed to maintain cell volume and [Cl-]i (AlvarezLeefmans, 2012; Delpire & Gagnon, 2006).

Significance

The unusual location of NKCC1, together with NKATP, on the apical
membrane of CPECs has led to much debate about the function of the cotransporter
in the choroid plexus, including its role in cerebrospinal fluid secretion. Uncertainty
of the direction of NKCC1-mediated activity under physiological conditions impedes
our understanding of CSF secretion and our ability to develop effective treatment
strategies to control conditions such as brain edema and hydrocephalus. Both
edema and hydrocephalus can occur subsequent to brain injury (Unterberg, Stover,
Kress, & Kiening, 2004), with hydrocephalus being more commonly linked with
intracerebral hemorrhages, usually resulting from a blood clot in a weakened artery,
that extend into the ventricles (Strahle et al., 2012). In the latter example, CSF
drainage is usually obstructed by swelling in the cerebral aqueduct, or at the
arachnoid villi or granulations (Strahle et al., 2012). As the pressure of CSF
increases, so does the chance of cell death and brain damage (Strahle et al., 2012).
Treatments for brain edema and hydrocephalus are often invasive, such as inserting
a drainage stent or performing a decompressive craniectomy, and come with a risk
of infection. By better understanding the mechanisms of CSF secretion at the
choroid plexus, non-invasive medications can be developed for the long-term
9

control of CSF secretion.

Whether CPECs utilize NKCC1 for CSF secretion is unclear. Blocking NKCC1
activity in the choroid plexus by intraventricular application of bumetanide results
in an ~50% reduction in both CSF secretion (Javaheri & Wagner, 1993) and apical
Cl- efflux (Johanson, Sweeney, Parmelee, & Epstein, 1990), as well as an ~50%
reduction Na+, K+, and Cl- uptake (Bairamian, Johanson, Parmelee, & Epstein, 1991;
Johnson, Singer, S., Hoop, B., Kazemi, H., 1987; Preston, Dyas, & Johanson, 1993).
Bumetanide also causes a reduction in CPEC water volume (Bairamian et al., 1991;
Wu et al., 1998). Equal reduction of both Cl- influx and efflux in the presence of
bumetanide suggests that NKCC1-mediated ion and associated water fluxes in
CPECs are inwardly directed under basal conditions and function to maintain the
cell water volume required for CSF secretion. Additionally, it is hypothesized that
NKCC1 is working near to its flux reversal point in CPECs, thus permitting the
cotransporter to function in both directions (Keep et al., 1994). The flux reversal
point, or chemical equilibrium, of NKCC1 is where the net chemical potential free
energy driving NKCC1 cotransport (∆μNKCC1) is equal to zero, given by the following
equation 1 for this electroneutral cotransporter:

(equation 1)

∆µ#$%%& = RT ∙ ln

#./ 0 ∙ $/ 0 ∙ %12 30
#./ 4 ∙ $/ 4 ∙ %12 34

,

where R is the Gas Constant (8.314 Joules/ Kelvin/ mole) and T is temperature in
degrees Kelvin. Reported values for the intracellular Na+ concentration of CPECs has
10

varied widely over the past few decades, and it is impossible to calculate the flux
reversal point for NKCC1 without knowing this concentration. Measurements using
ion-selective microelectrodes in amphibian CPECs report a [Na+]i =10.5 mM (Saito &
Wright, 1987), in contrast to mammalian measurements, using ion tracers and flame
photometry, that asserted that CPECs have [Na+]i as high as 48 mM (Johanson &
Murphy, 1990). It should be noted that the latter measurement technique damages
cells, they are whole tissue measurements of total ion content where extra- and
intracellular water contents are subject to significant errors, usually yielding
erroneously high ion concentrations. Thus, these techniques measure total Na+ (free
plus bound) and the thermodynamically relevant parameter is the free Na+ ion
(Harootunian, Kao, Eckert, & Tsien, 1989). Most animal cells have a low [Na+]i of
approximately 10 mM that is maintained by NKATP, and other ion cotransporters,
including NKCC1, utilize the chemical potential energy stored in the Na+ gradient
across the plasma membrane to cotransport ions and molecules into the cell. An
[Na+]i as high as that reported by Johanson and Murphey (1990) may significantly
alter the driving force of cotransporters on CPECs. Measurements and predictions of
high [Na+]i have been cited as evidence to support NKCC1 working in the outward
direction, however the validity of these measurements is questionable for the
reasons given above. Having a clear comprehension of the biophysical
characteristics of CPECs, especially ion transport, is fundamental to the knowledge
of CSF secretion and homeostasis. This knowledge is key to develop treatment
strategies in which the control of CSF production or its regulation is needed, such as
with primary or secondary intracranial hypertension, because NKCC1 is a potential
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pharmacological target for controlling CSF secretion (Kahle et al., 2009; Karimy et
al., 2016; Lu et al., 2006).
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Chapter 2: General Methods
Animals

NKCC1 -/- mouse breeders, developed from C57/129 Swiss mouse strains on a
mixed background (a generous gift from Dr. Gary Shull, University of Cincinnati),
were used to develop our NKCC1 -/- colony. All experiments were performed with
NKCC1 -/- mice derived from this colony or their WT littermates. The Wright State
University Laboratory Animal Care and Use Committee approved the housing,
handling, and use of all mice in accordance with National Institutes of Health
guidelines.
In every experiment in which NKCC1 -/- mice were used, the animal’s genotype
and phenotype were tested to ensure that it was a homozygous knockout. NKCC1 /- mice have slowed growth and are smaller than their +/- and +/+ littermates, they
are deaf, and they display shaker/ waltzer behavior that manifests as the mouse
shaking and spinning in circles (Delpire, Lu, England, Dull, & Thorne, 1999; Flagella
et al., 1999). An NKCC1 -/- mouse had to display these three phenotypes to be used
for experiments. The imbalance seen in NKCC1 -/- mice is the result of a collapsed
cochlear duct containing a K+-rich endolymph generated by NKCC1 (Delpire et al.,
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1999; Flagella et al., 1999). NKCC1 -/- mice also have reduced blood pressure,
severely impaired saliva production, and a 28% incident of death by weaning at
postnatal age (P) 21 days (Evans et al., 2000; Flagella et al., 1999). Due to the latter
phenotypes, all NKCC1 -/- mice were euthanized at P21, if they were not used for an
experiment.

Genotyping

The procedure used to genotype NKCC1 -/- mice was performed using 1 –3 mm
of tissue obtained from mouse-tail clips performed during postnatal days 3 –6. Tail
clips were processed and the DNA extracted using Qiagen DNeasy Blood and Tissue
Kit for Spin-columns. Polymerase chain reaction (PCR) amplification was
performed in 21 µL and containing: 13.4 µL ultra-pure water, 0.4 µL Taq DNA
Polymerase (GenScript), 4 µL 10x Taq Buffer (Invitrogen), 1 µL dNTP (10 µM,
USB/Affimetrix), 1.2 µL mouse NKCC1 (mNKCC1) custom primers (see Table 2.1,
Integrated DNA Technologies), and 0.5 µL mouse DNA. The PCR reaction was
performed using a thermocycler (BioRad) under the following protocol: 4 min 95°
C; 34 cycles (30 sec 95° C, 30 sec 60° C, 50 sec 72° C); 10 min 72° C; hold at 0° C.
PCR products weights were separated using a gel electrophoresis bath in a 2%
agarose gel.
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Table 2.1: mNKCC1 custom PCR Primers
Primer

Sequence

mNKCC1 5’

GGAACATTCCATACTTATGATAGATG

mNKCC1 3’

CTCACCTTTGCTTCCCACTCCATTCC

mNKCC1 neo

GACAATAGCAGGCATGCTGG

Lists the custom mNKCC1 primers used for genotyping NKCC1 -/- mice.

Isolation of single CPECs

Mice, P10-P21, were anesthetized using CO2 then euthanized by rapid
decapitation. As detailed in Figure 2.1, the brain was removed and immediately
submersed into room temperature Dulbecco’s Phosphate Buffered Saline (DPBS,
Life Technologies, no Ca2+ & no Mg2+), pH 7.1, and the CP of the fourth ventricle was
visualized and dissected-out under a 20X microscope. The dissected CP was
incubated for 1 hour in 1 mL of dissociation media that was composed of culture
media supplemented with protease XIV (0.5 mg/ mL, Sigma Aldrich) and
collagenase IV (0.5 mg/ mL, Sigma Aldrich). Culture media was prepared the day of
the experiment, and the following ingredients were brought to room temperature,
combined into, and pass through a 10 mL lauer-lock syringe attached to a sterile
filter (33 mm Millex -GP Express PES 0.22 µm, Merck Millipore) before use: DMEM/
F12 (HyClone-Fisher), 10% heat-inactivated FBS (Gibco-Fisher), penicillin/
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streptavidin (HyClone-Fisher, 10 U/ mL: 10 µg/ mL), and hEGF (40 ng/ mL).
Following the incubation, the dissociation media was aspirated off and the CP was
rinsed 3X with culture media before the final volume of 500 µL of culture media was
added. To dissociate the cells, the CP in culture media was vigorously shaken with a
vortex shaker for 3 seconds, after which the cells were gently triturated with firepolished glass Pasteur pipettes of two different bore diameters that were equivalent
to 23 and 32 gauge needles (used in that order), 20X per bore size. Cells were
plated on laminin (Sigma Aldrich, No. L-2020, 5 µg /ml) and poly-D-lysine (BD
Bioscience, No. 354210, 100 µg /ml) coated 25-mm sterile and de-greased cover
slips (Electron Microscopy Sciences, No. 72196-25). Degreased cover slips were
soaked for 24-72 hours in acetone (Fisher) then rinsed 3x first in 70% ethanol
(Fisher, diluted with double distilled water (ddH2O)) followed by a 3x rinse in
ddH2O prior to being sterilized to remove any manufacturing residues. Plated cells
were incubated at 5% CO2 –95% air atmosphere /85 –95% humidity /37° C for 2 –6
hours prior to use for experimentation.
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Figure 2.1: Dissection of the CP of the 4th ventricle in mouse. The dissected
mouse brain was immediately submerged into a silicone lined dissection plate
that contained sterile room temperature DPBS. Two 23 gauge needles were
used to secure the brain ventral-side-up in the silicone at the points marked with
X. The tissue was illuminated and visualized under a 20X dissection microscope.
A pair of #4 micro-forceps was used to gently pick-up the brain stem (at point A)
and fold it upwards so that the ventral surface of the brain was in contact with the
ventral surface of the brain stem (B). The CP (D) was located by following the
dorsal mid-line (C) in the posterior direction towards the cerebellum. The CP of
the 4th ventricle is Y-shaped, and, with a second pair of #4 forceps, each “arm” of
the CP was first freed from the connective tissue and vasculature before the
entire CP was dissected-out in one piece.

17

Saline Solutions
HEPES-buffered solutions

The isosmotic (ISO) physiological control solution, herein referred to as
artificial CSF (aCSF), contained 123.5 mM NaCl, 3 mM KCl, 1 mM CaCl2, 1.25 mM
MgCl2, 5 mM HEPES, and 10 mM glucose. The pH adjusted to 7.3 at 25° C with 1 M
NaOH, and the osmolality adjusted to 290 ± 1% mOsm with sucrose. Isosmotic
nominally chloride free (0Cl) and isosmotic nominally sodium free (0Na) solutions
were made by mole-for-mole replacement of Cl- with gluconate and Na+ with NMDG
(N-methyl-D-glucamine) + HCl, respectively. Solutions with various [K+]o were
made by adding the corresponding volume of 3 M KCl prior to adjusting the
osmolality with sucrose. Osmotic calibration solutions were created by adjusting
the amount of sucrose in the ISO to 261 ± 1% mOsm for the 10% hyposmotic
solution and 319 ± 1% mOsm for the 10% hyperosmotic solution. The osmolality of
all solutions was measured with a Wescor osmometer.

Bicarbonate-buffered solutions

Bicarbonate buffered aCSF solutions contained 105.2 mM NaCl, 2 mM
NaH2PO4, 1 mM CaCl2, 1.25 mM MgCl2, 3 mM KCl, 10.5 mM Glucose, and 24.8 mM
NaHCO3. The pH adjusted to 7.3 by slowly adding the NaHCO3 after the solution has
been bubbled for 20 min with 5% CO2 balanced with air, and the osmolality adjusted
to 290 ± 1% mOsm with sucrose. Osmotic calibration solutions and isosmotic
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solutions with variations in [K+]o were made in the same manner as with the HEPES
buffered solutions.
Drug and Chemical Preparation

Stock solutions of chemicals were prepared using dimethyl sulfoxide (DMSO) or
water as the initial solvent, and then diluted using aCSF. When DMSO was used as
the solvent, care was taken to ensure that the final amount of total DMSO in the
solution was less than 1%. This preparation was used for Bumetanide, Ouabain,
Verapamil, Calcein-AM, Asante Natrium Green-2 (ANG-2), and N(Ethoxycarbonylmethyl)-6-Methoxyquinolinium Bromide (MQAE).

Fluorescence imaging microscopy

Cover slips with attached CPECs were mounted into a fluid perfusion imaging
chamber (~300 µL volume) that rested on the stage of an epifluorescence inverted
microscope (Olympus IX-81, Olympus America, Center Valley, PA) equipped with an
oil-immersion lens (Olympus, 40X, NA 1.35) and differential interference contrast
(DIC) optics (Figure 2.2). Physiological solutions were perfused over the cells at a
rate of 6 mL/ min at 25° C, and changes in fluorescence intensity of individual cells
were measured through a digital pinhole (15 x 15 pixels for calcein and MQAE, and
20 x 20 pixels for ANG-2) using MetaSeries Software (Alvarez-Leefmans, HerreraPerez, Marquez, & Blanco, 2006). Light originating from a xenon arc lamp was
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directed through the input slit of a monochromator (Optoscan, Cairn Research
Limited, UK) that allowed independent control of both the wavelength of light and
the output slit width of the beam of light emitted. The light beam then passed
through a liquid guide and neutral density filter to reduce photodynamic damage
and photo-bleaching prior to entering the optical path of the microscope. To use
Calcein as an example, the excitation wavelength for calcein is 495 ± 3 nm and the
peak emission occurs at 535 nm, thus a 515 nm dichroic mirror/ 535 emissions
filter cube (Chroma Technology) was used to reflect excitation wavelengths below
515 nm into the inverted objective where it excited the fluorophores within the
cells. Any wavelengths above 515 nm, calcein emissions, were able to pass back
down through the dichroic mirror and reached the 535 nm emissions filter below.
The emission filter prevented stray light, outside the emission filter wavelength of
535 ± 13 nm, from reaching the cooled CCD camera (Hamamatsu ORCA-ER C474295). To further reduce photodynamic damage to CPECs, the shutter speed was kept
between 40 –80 ms and fluorescence acquisition frequency was 0.1 –0.25 Hz.
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Figure 2.2: Microscope set-up for quantitative fluorescence imaging microscopy. Imaging setup used to record
CWV changes and/or intracellular Na+ and Cl- in single CPECs loaded with calcein or ion-indicator. The filter’s
wavelengths are shown for Calcein. This figure is modified from Alvarez-Leefmans, F. J., Herrera-Perez, J. J., Marquez,
M. S., & Blanco, V. M. (2006). Simultaneous measurement of water volume and pH in single cells using BCECF and
fluorescence imaging microscopy. Biophysical Journal, 90(2), 608-618, and is reproduced with permission.
21
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Figure 2.3: Basic principles and methods for measuring changes in CWV. NKCC1-mediated ion transport is tightly
linked to water transport (Hamann et al., 2010), thus the direction and relative magnitude of NKCC1-mediated fluxes can
be inferred by measuring changes in relative CWV in single CPECs. A) from Alvarez-Leefmans, F.J. (unpublished),
reproduced with permission. Two models explaining how NKCC1-mediated ion transport is tightly linked to water
transport. B) This figure is modified from Alvarez-Leefmans et al., (2006). Simultaneous measurement of water volume
and pH in single cells using BCECF and fluorescence imaging microscopy. Biophysical Journal, 90(2), 608 -618. Basic
principle for measuring relative CWV through a pinhole in CPECs using live-cell imaging fluorescence microscopy in
dissociated CPECs loaded with the fluorescent probe calcein (Alvarez-Leefmans et al., 2006), and reproduced with
permission.
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Measurement of cross-sectional area of in vitro CPECs

Using the microscope set-up described above, freshly dissociated CPECs from
WT and NKCC1 KO mice were visualized and imaged using differential interference
contrast (DIC) microscopy. The perimeter of each living cell imaged with DIC was
digitally outlined offline using a mouse, and cross-sectional areas of individual cells
calculated using MATLAB (Math Works), using algorithms developed by Mr. Aaron
Madaris. Cells were loaded with Calcein-AM, which was used for subsequent parts of
the experiments to measure CWV changes, but also indicated cell viability. Only cells
that were loaded with Calcein were measured using DIC imaging. Each cell within
the field was identified with a color-coded pinhole and a number.

Method to measure cell water volume changes in single CPECs

NKCC1-mediated ion fluxes are tightly linked to water fluxes that occur
either through the cotransporter or through aquaporins (Figure 2.3A) (AlvarezLeefmans, 2012; Hamann et al., 2005; Hamann et al., 2010; Macaulay & Zeuthen,
2012). Therefore, changes in cell volume can be measured as a surrogate for
NKCC1-mediated fluxes (Alvarez-Leefmans et al., 2006; Hamann et al., 2010).
Changes in the fluorescence intensity of intracellular free Calcein are inversely
proportional to changes in cell water volume (Figure 2.3B), according to the
following equation 2 from Alvarez-Leefmans et al., (2006):
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(equation 2)
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CWV =
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,

where CWV is relative cell water volume, Qm is total intracellular content of the dye
(m), and Cm is the relative change in concentration of m. CWV can be determined by
measuring changes in Calcein fluorescence (Cm) as long as Qm is constant (AlvarezLeefmans et al., 2006). Calcein was loaded by exposing the cells to a solution
containing of 2 μM of Calcein-AM (Invitrogen) along with 20 μM Verapamil
(Invitrogen). Verapamil was added to inhibit the multi-drug resistant P-glycoprotein
that is expressed in CPECs and can remove fluorescent dyes from the cell (Rao et al.,
1999 Snyder, Finch, Sartorelli, Piwnica-Worms, 1999; Robertson, 1995; Valverde et
al., 1996). Calcein was excited at 495 ± 3 nm for 80 ms at a frequency of 0.25 Hz and
the emission recorded above 515 nm. Volume calibration was performed for each
cell with ± 10% anisosmotic solutions.

Data analysis was performed using SigmaPlot versions 9 & 12, and Microsoft
Excel. When required, drift correction of the Calcein transient was performed using
a linear regression. Calcein fluorescence was converted to CWV using the following
equation 3 (Alvarez-Leefmans, 1995):

(equation 3)
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where Vt is cell water volume with respect to time of the entire transient, Vo is Vt at t
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= 0, Ft is the measured fluorescence intensity with respect to time, Fo is the steadystate fluorescence intensity at baseline (during ISO), and FBackground is the
background fluorescence of the cell that is insensitive to changes in CWV.

Measurement of intracellular chloride in single CPECs

The [Cl-]i of CPECs was measured using the fluorescent indicator MQAE (N(Ethoxycarbonylmethyl)-6-Methoxyquinolinium Bromide, Invitrogen). MQAE is a
single wavelength indicator that detects Cl- through collisional quenching (Verkman,
Sellers, Chao, Leung, & Ketcham, 1989). The method for measuring [Cl-]i in CPECs
follows the procedure used in other cell types (Mao et al., 2012; Rocha-Gonzalez,
Mao, & Alvarez-Leefmans, 2008). MQAE was applied to the chamber containing
CPECs at a concentration of 5 mM and with 20 μM Verapamil. The dye was excited
at 350 ± 5 nm for 20 ms at a frequency of 0.1 Hz; the peak emission wavelength was
460 nm captured every 10 seconds. CPECs were equilibrated in isosmotic aCSF
prior to Cl- depletion by exposing the cells to an isosmotic 0Cl solution. Once a new
steady state was reached in the 0Cl solution, the CPECs were considered fully
depleted of intracellular Cl-, and external Cl- was replaced with isosmotic aCSF. At
the end of the experiment MQAE was calibrated against [Cl-]i using the double
ionophore technique (Koncz & Daugirdas, 1994; Krapf, Berry, & Verkman, 1988;
Mao et al., 2012; Rocha-Gonzalez et al., 2008). CPECs were permeabilized with the
K+/H+ ionophore Nigericin (5 μM, Sigma Aldrich) and the Cl-/ OH- ionophore
Tributyltin Acetate (10 μM, Sigma Aldrich). Calibration solutions contained 10 mM
Glucose, 5 mM HEPES, 120 mM K+, and [Cl-] + [NO3-] = 120 mM. The calibration
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steps were 0, 20, 40, and 60 mM Cl- and then MQAE was quenched with a final
solution of 150 mM KSCN to set the background.

MQAE signal drift correction was performed offline by fitting the entire data
transient to a straight line (Mao et al., 2012; Rocha-Gonzalez et al., 2008). The
correlation coefficient of the fit was ³ 0.99 for the cell to be included in the analysis.
MQAE fluorescence data was then converted to [Cl-] using the Stern-Volmer
equation:

(equation 4)

[Cl/ ]? =

((.., )/;)
+

@AB

where Fo = the steady-state fluorescence during chloride depletion using the 0Cl
solution, Ft = fluorescence measurements with respect to time, and Ksv = SternVolmer Constant. Ksv was obtained by plotting the mean fluorescence
measurements of the calibration steps to the Stern-Volmer Graph (Fo/Ft) –1 vs. [Cl-]
and taking the slope as Ksv. The mean Ksv for the intracellular calibration of MQAE in
WT CPECs was within the normal range at 17.0 ± 0.6 M-1 (mean ± SEM, n = 5
animals) and the mean KSV of KO CPECs was 10.4 ± 1.2 M-1 (n = 7 animals). In other
cell types the reported values for intracellular Ksv is 5 –25 M-1 (Kaneko, Putzier,
Frings, Kaupp, & Gensch, 2004; Mao et al., 2012). Further, the MQAE analysis
followed three constraints described in Mao et al., 2012. Briefly, for a cell to be
included in the analysis 1) the correlation coefficient for the line fitting the
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calibration plot ³ 0.99, 2) MQAE fluorescence in each calibration solution reached
steady state, and 3) MQAE fluorescence in the both the isosmotic aCSF and 0Cl
solutions reached steady state (Mao et al., 2012). The Cl- equilibrium potential (ECl)
was calculated from the Nernst equation:

(equation 5)

E(D =

EF
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ln

[(DI ]J
[(DI ],

where z (= -1) is the valence of Cl-, R is the gas constant, T is temperature, and F is
the Faraday constant.

Measurement of intracellular sodium in single CPECs

Measurements of [Na+]i were done with the fluorescent sodium indicator
dye Asante Natrium Green 2 (ANG-2) (TEFLabs, 2012). CPEC [Na+]i measurements
were first attempted with SBFI, but the cells could not be successfully loaded with
the indicator. ANG-2 has a similar Na+ binding affinity as SBFI, and was developed as
an alternative Na+ indicator (Lamy & Chatton, 2011; Roder & Hille, 2014). Unlike
SBFI, ANG-2 is a single wavelength dye with excitation and emission wavelengths at
488 –517 nm (peak excitation at 517 nm) and 540 nm, respectively (Lamy &
Chatton, 2011; TEFLabs, 2012). The benefit of ANG-2 is that it is easier to load into
cells and the excitation wavelength is less damaging compared to the near
ultraviolet excitation wavelengths of SBFI. ANG-2 was applied to the cover slip at
concentration 5 μM, along with an equal volume of the nonionic detergent Pluronic
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F-127 (20% weight/ volume) and verapamil (20 μM). During the data acquisition
the excitation wavelength was set at 500 ± 10 nm for 80 ms at a frequency of 0.1 Hz.
The fluorescence intensity of each cell was sampled every 10 seconds until a steadystate was achieved, and then calibration of the dye was done at the end of each
experiment to determine [Na+]i. At the start of calibration cells were treated with a
nonselective monovalent cation ionophore, Gramicidin D (7 μM, Sigma Aldrich), to
collapse the Na+ and K+ gradients across the cell membrane (Robertson, 1995).
Calibration solutions contained 10 mM HEPES, 1.2 mM Ca2+, 57.4 mM Cl-, 65 mM
gluconic acid, with [Na+] + [K+] = 120 mM, pH= 7.3, and 290 mOsm, adjusted with
sucrose. The calibration points were 120, 90, 60, 30, 12, and 6 mM Na+.

To analyze the fluorescence measurements, the data transient was first
normalized to the 0Na calibration steady-state measurements using the equation 6:

(equation 6)

1-Fo/Ft,

where Fo = mean fluorescence measurements during the 0Na calibration at steadystate, Ft = the fluorescence measurements with respect to time of the entire
transient, and it was subtracted from 1 so that the data was not inverted. The mean
measurement for each Na+ Calibration solution was then used to plot the graph 1Fo/Ft vs. [Na+] (mM). From this graph, a regression curve was fitted using the
Michaelis-Menton equation,

29

(equation 7)

y=
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and a report was created giving the Fmax and Kd values for each individual cell. The
normalized data (1-Fo/Ft) was then converted into [Na+] using the following
equation 8 that was based on the Ca2+ indicator FURA-2 and modified here for ANG2 (Grynkiewicz, Poenie, & Tsien, 1985):

(equation 8)

NaQ = K U ∙

(0/ 0'J8 )
(0'2L / 0)

Where F = the normalized data 1-Fo/Ft, Fmin = 0, Fmax and Kd were taken from the
report.

Method for immunofluorescence labeling of NKATPa1 and aquaporin 1
(AQP1)

Brain and kidney tissues of WT and NKCC1 KO mice, P17-19, were used to
verify the polarized expression of NKATP and AQP1 in the CPECs NKCC1 KO mice.
After animal fixation, tissue was post-fixed using 4% Paraformaldehyde for 1 -2
hours prior to cryoprotecting in 15% sucrose. Cryostat sectioning of tissue (10 μm)
was mounted directly onto slides to protect the CP.

AQP1: Sections were permeabilized using 0.1% Triton-X and blocked for 30
minutes with 10% goat serum before overnight incubation in a humidity chamber at
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4° C using rabbit polyclonal antibody against rat AQP1 (5 μg/ mL, Alpha
Diagnostics). The sections were washed 3x 5 min in 0.01 M PBS both before and
after a 1.5-hour incubation with goat anti-rabbit Alexa 594 (1:200, Jackson
ImmunoResearch). The coverslip was mounted using ProLong Gold Anti-fade
reagent with DAPI (Invitrogen).

NKATPa1: Tissue was stained using Vector Mouse on Mouse (M.O.M.)
Antibody Kit. Briefly, sections were permeabilized in ice-cold acetone at -20° C for
5-10 minutes and were allowed to air dry. Sections were washed 2x 2 minute in
0.01M PBS prior to the application of each solution. To start, there was a 1-hour
incubation in M.O.M. Mouse Ig Blocking Reagent solution. The sections were then
incubated for 30 minutes in M.O.M. Diluent solution that contained the mouse
monoclonal NKATP-α1 subunit antibody (4 μg/ml, Millipore), followed by a 10minute incubation in M.O.M. Biotinylated Anti-Mouse IgG Reagent solution, and a 5min incubation in Fluorescein Avidin DCS solution. Sections received a final 3x 3
minute PBS wash before they were mounted on coverslips with either ProLong Gold
w/ DAPI or VectaShield Anti-Fade Reagent.

Statistics

Data is presented as the mean ± standard error of the mean (SEM), n =
number of animals. Individual animal means were calculated by taking the mean of
the cells obtained from that animal, then those means were averaged and the SEM
calculated using Microsoft Excel. Comparison of ion concentrations between CPECs
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from WT and NKCC1 KO was performed using an unpaired Student’s t-test for
independent samples in Sigma Plot version 9.
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Chapter 3: Specific Aims
The overall objective this research is to understand how CPECs secrete CSF
and regulate its ionic composition in order to find safe and more effective treatment
strategies to control CSF secretion, The Central Thesis: NKCC1 functions as a
sensor and regulator of CSF [K+] in the apical membrane of CPECs by working near
to its flux reversal point and in the inward direction under basal physiological
conditions. The Km for external K+ and the thermodynamic features of NKCC1
enables it to reverse net flux direction in response to small (± 2 mM) changes in
external [K+]. To prove this thesis the two following aims have been developed:

1) Determine the direction NKCC1-mediated ion and associated water net
fluxes in CPECs under basal conditions. Hypothesis: A function of NKCC1 in
CPECs is maintenance of both normal and constant cell water volume. Under basal
physiological conditions NKCC1 is constitutively active, inwardly transporting ions
and associated water. Epithelial cell volume maintenance requires equal rates of
solute and water entry and exit across the apical and basolateral membranes,
respectively (Ruess, 1988). Hence, we predict that NKCC1 inactivation results in
CPEC shrinkage due to unbalanced solute and water fluxes.

33

The direction of NKCC1 activity can be inferred by measuring cell water
volume in the presence and absence of NKCC1 transport activity. NKCC1 activity is
inhibited in this research using a three-pronged approach that includes
pharmacological inhibition of the cotransporter, genetic ablation of the NKCC1
protein, and ion-substitution experiments. Pharmacological inhibition of NKCC1 is
performed using the loop-diuretic bumetanide and genetic ablation via the global
NKCC1 knockout (KO) mouse. Using these approaches controls for any unknown
variables, such as a compensatory mechanism, that may be present with the NKCC1
global KO mouse model (Eisener-Dorman, Lawrence, & Bolivar, 2009; Nelson,
1997). Additionally, the extracellular ion dependence of changes in CWV is
examined to determine whether the apical location of NKCC1 impacts the function
of this cotransporter as a Cl- loader, given that the CP is considered a Cl- secretory
epithelium.

2) Test the hypothesis that NKCC1 functions as a sensor and regulator of CSF
[K+] in CPECs. Hypothesis: NKCC1 is working near to its chemical equilibrium in
CPECs, therefore small changes in [K+]o are sufficient to alter both the direction and
magnitude of NKCC1-mediated ion and associated water fluxes.

Experiments will test the sensitivity of NKCC1 to small changes in [K+]o in
CPECs by comparing the responses of cells from NKCC1 KOs to those from WT mice.
The flux reversal point of NKCC1 in CPECs is calculated by modeling the net free
energy driving NKCC1 cotransport with respect to [K+]o. Our model predicts that
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apical NKCC1 is working in the net inward mode under basal conditions, and near to
chemical equilibrium, i.e., its flux reversal point. Consequently, CPECs can utilize
NKCC1 to sense and control the K+ uptake and/or secretion in response to the
[K+]CSF.
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Chapter 4: Specific Aim 1 Results

Testing the hypothesis of Specific Aim 1 requires that the following questions
be answered:
1) What is the direction of NKCC1-mediated fluxes in CPECs under
physiological conditions?
2) Is NKCC1 constitutively active and functioning to maintain normal and
constant cell water volume in CPECs?
Knowing the direction of NKCC1-mediated fluxes under basal physiological
conditions is critical to understanding how this cotransporter functions on the
apical membrane of CPECs, and whether NKCC1 contributes to CSF secretion
directly vs indirectly. If NKCC1 is constitutively active and functions in the
maintenance of CPEC water volume, then NKCC1-mediated fluxes contribute
indirectly to CSF secretion, as opposed to a direct contribution to CSF secretion via
ion efflux. Given that NKCC1 is phosphorylated and activated in response to cell
shrinkage or a decrease in [Cl-]i, we predict that in CPECs the NKCC1-mediated
fluxes are inwardly directed under basal physiological conditions, and indirectly
contribute to CSF secretion by maintaining both normal and constant cell water
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volume needed for sustained activation of volume-sensitive transporters and
channels.

Morphometric comparison of the cross-sectional areas of CPECs from
NKCC1 KO and WT mice

Cell water volume is maintained by balancing the net influx and the net efflux
of solute and water across the plasma membrane. Removing NKCC1-mediated ion
fluxes will unbalance the net trans-epithelial solute and water fluxes and reveal the
direction of cotransport (Figure 4.1), because epithelial cell volume maintenance
requires equal rates of solute and water influx and efflux across the apical and
basolateral membranes (Ruess, 1988). CPECs are reported to shrink when NKCC1 is
blocked with bumetanide, suggesting that the cotransporter is constitutively active
and inwardly directed in these cells (Bairamian et al., 1991; Wu et al., 1998).
Bairamian et al., (1991) found that 10 µM bumetanide reduced CP water weight by
20 mg H2O/ g tissue, and Wu et al., (1998) observed a ~9% reduction in the CSA of
dissociated rodent CPECs after exposure to both 10 and 100 µM bumetanide,
although they only showed data for the highest bumetanide concentration. Later
studies challenged these findings and interpretations based on the observations that
bumetanide at concentrations of 100 µM caused a reduction in CPEC volume, but
not at concentrations of 10 µM (Brown, Davies, and Millar, 2009; Hughes,
Pakhomova, & Brown, 2010). Both groups of researchers used DIC microscopy that
yields total cell volume and have relatively low-resolution due to edge/ hallow
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effect, needing a large number of cells to increase the signal to noise ratio to reach
reliable conclusions. We addressed this controversy by measuring changes in CWV
of CPECs from NKCC1+/+ exposed to 10 µM bumetanide, and ruled out unspecific
effects of this compound by using CPECs from NKCC1-/-. Changes in CWV were
assessed by intracellular Calcein dilution, a live-cell imaging microscopy method
that can resolve changes in CWV of ~1% with time resolution of 0.25 Hz, and allows
osmotic calibration of each cell (Crowe, Altamirano, Huerto, & Alvarez-Leefmans,
1995; Alvarez-Leefmans, 1995; Rocha-Gonzalez et al., 2008). We also used DIC livecell imaging microcopy to measure CSAs of isolated CPECs. The rational is that if
NKCC1 is constitutively active (i.e., it is always on), and works in the net ion and
water influx mode under basal conditions, then CPECs from NKCC1 KO mice should
also be shrunken compared with those from WT mice. Thus, shrinkage occurs
because the net influx of solute and water will be reduced compared to the net efflux
of solute and water.
A morphometric comparison of the CSA of individual dissociated CPECs
revealed that CPECs from NKCC1 -/- mice were smaller than those from WT mice.
The mean CSA measurements from both groups were normally distributed.
Measurements of the cross-sectional area of CPECs (Figure 4.2) revealed that CPECs
from WT mice had a mean cross-sectional area of 155 ± 4.1 μm2 (n = 44 animals),
whereas those from NKCC1 KO mice had a mean cross-sectional area of 137 ± 4.8
μm2, p = 0.0106 (n = 22 animals). Therefore, CPECs from NKCC1 KO animals were
~18 μm2 smaller than those from WT. DIC images of dissociated CPECs from sibling
WT and NKCC1 KO showed some additional subtle morphological differences
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Figure 4.1: Balance of net solute and water fluxes determines choroidal
epithelial cell volume. A function of NKCC1 in CPECs is maintenance of both
normal and constant CWV. Under normal physiological conditions NKCC1 is
constitutively active, inwardly transporting ions and associated water. Hence, we
predict that NKCC1 inactivation results in CPEC shrinkage due to unbalanced
solute and water effluxes.
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CPECs from NKCC1 -/- mice are significantly
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Figure 4.2: CPECs from NKCC1 -/- mice are significantly smaller than
CPECs from WT mice. Top) In vitro CPECs from WT (left) and NKCC1 KO (right)
sibling animals. CPECs from NKCC1 KO mice were visually smaller than those from WT
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mice. Bottom) CPECs from WT mice had a mean cross-sectional area of 155 ± 4.1 μm2
(dotted line in box plot), n = 44 animals. CPECs from NKCC1 KO mice were -11.5%
smaller than those of the WT and had a mean cross-sectional area of 137 ± 4.8 μm2, p
= 0.0106, n = 22 animals. Boxplot illustrates the spread of CSA measurements with
median CSA denoted as a black line, the box represents the 1st and 3rd quartiles, stems
represent quartiles 0 and 4, and the dots are those values beyond the quartile spread.
Both groups of measurements were fitted to a Gaussian distribution.
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between the two groups. In the image from NKCC1 +/+, the dense microvilli of the
apical membrane were observed by the bumpy texture of the CPECs. In comparison,
the CPECs from the NKCC1 -/- animal appeared slightly smaller and smoother
suggesting that these cells were shrunken.

Effect of Bumetanide on cell water volume of CPECs from NKCC1 -/- and
NKCC1 +/+ mice

Using the pharmacological approach to verify our measurements, we also
measured the change in CWV of dissociated CPECs loaded with Calcein and exposed
to bumetanide (Figure 4.3). When 10 μM bumetanide was applied to CPECs from
WT mice the cells shrunk an average of -15.9 ± 9.1% (n = 3 animals), at an initial
rate of -5.4 ± 0.6 %/ min. CPECs from NKCC1 KO mice did not respond to 10 μM
bumetanide, mean volume change was equivalent to noise at < ± 1% (-0.5 ± 0.7 %, n
= 3 animals). By treating CPECs attached to the cover slips as hemispherical domes,
we used the measurements of CSA to estimate the predicted reduction in CWV of
NKCC1 -/- CPECS and compared it to that resulting from 10 µM bumetanide
exposure (Table 4.1). What we found was that NKCC1 -/- CPECs had a predicted
difference in CWV of approximately -16%, which corresponded to the 15.9% loss in
CWV in WT CPECs that followed exposure to 10 µM bumetanide. This similarity in
CWV loss suggested that 10 µM bumetanide produced nearly complete inhibition of
the NKCC1 cotransporter in CPECs. In conclusion, blocking NKCC1-mediated ion and
associated water fluxes in CPECs by either pharmacological blockade by bumetanide
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or genetic ablation of NKCC1 resulted in CPEC shrinkage. These results strongly
suggest that on the apical membrane of CPECs NKCC1 is constitutively active and
functions in the inward mode.

External ion dependence of cell water volume in CPECs

We also examined the external Cl- and Na+ dependence of CWV in CPECs. By
examining the changes in CWV that occurred during Cl- uptake in the presence and
absence of NKCC1, we could infer the contribution of NKCC1 to Cl- loading. This
inference is possible given that ion transport mediated by NKCC1 is tightly linked to
water transport in epithelial and non-epithelial cells (Hamann et al., 2010; RochaGonzalez et al., 2008; Zeuthen & Macaulay, 2012). The removal of extracellular Cl(replaced with gluconate) depleted WT CPECs of Cl- and water, and resulted in a
mean cell shrinkage of -20.3 ± 1.8% (n = 10 animals), with an initial rate of -43.9 ±
8.0 %/min (Figure 4.4, A). This shrinkage reversed when Cl- was reintroduced. In
contrast to cells obtained from WT animals, CPECs from NKCC1 KO mice only
shrank by -7.7 ± 2.1% (n = 4 animals), during isosmotic removal of Cl-, with an initial
rate of cell shrinkage of -12.7 ± 3.9 %/min (Figure 4.4, B). These results support our
hypothesis that NKCC1-mediated ion and associated water fluxes are constitutively
active, inwardly directed, and function to maintain normal CWV under basal
conditions.
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Figure 4.3. Blocking NKCC1 with bumetanide causes NKCC1 +/+ CPEC shrinkage.
Top) volume recording of an individual CPEC from a WT mouse. The trace
began with the two ± 10% hypo- / hyperosmotic calibration pulses, prior to the
application of bumetanide. In this particular cell, bumetanide caused ~ 13%
decrease in CWV, which was recovered during the drug wash out. Bottom) The
same experiment was repeated in a CPEC from an NKCC1 -/- mouse. NKCC1 /- CPECs responded well to the calibration pulses, but failed to respond to
bumetanide due to the loss of NKCC1-mediated fluxes.
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Table 4.1: Predicted difference in CPEC volume using CPEC CSA’s

Using the mean CSA (from Figure 4.2), the radius was calculated and inserted
into the formula for the volume of a hemisphere. The predicted difference in
volume between the WT and NKCC1 -/- CPECs was very close to mean volume
difference found by inhibiting the cotransporter with 10 µM bumetanide.
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Once CPECs were depleted of Cl-, we observed the external Na+ dependence
of CWV recovery by the simultaneous replacement of extracellular Cl- and removal
of extracellular Na+ (replaced with N-methyl-D-glucamine). By removing external
Na+, we inhibited all Na+/Cl- co-transport into the cell. CWV recovery was partially
inhibited in the absence of Na+, and the volume recovered to -15.8 ± 4.0% (n = 3
animals) during the Na+-free recovery. About 75 —80% of this CWV recovery was
Na+-dependent. The rate of volume recovery during the sodium-independent
component (SIC) was slower, 2.6 ± 0.1%/min, compared to the rate during sodiumdependent component (SDC), 30.2 ± 12.6%/min (n = 3 animals) (Figure 4.4, D).
Given that NKCC1 functions as an active Cl- uptake mechanism in other Cl- secreting
epithelia, it is likely that the SDC of CWV recovery that followed CPEC Cl- depletion
was mediated by apical NKCC1, and the SIC likely resulted from the combined
effects of the Anion Exchanger 2, NKATP, and osmotically committed water (Brown
et al., 2004).

To test the hypothesis that NKCC1 was contributing to the CWV recovery that
followed Cl- depletion, CWV recovery was examined in the presence of bumetanide.
Volume recovery following CPEC shrinkage with 0Cl in the presence of bumetanide
(10 μM) produced a small bumetanide-independent volume recovery to -13.0 ± 1.2
%, with an initial rate of 8.3 ± 0.1 %/min, followed by a very slow bumetanidedependent volume recovery when the drug was washed off 2.6 ± 0.003 %/min (n =
3 animals) (Figure 4.4, C). The bumetanide-insensitive (BIC) and Na+-independent
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Figure 4.4: External Chloride and Sodium dependence of CPEC CWV.
Gregoriades, Madaris, Alvarez, and Alvarez-Leefmans (2017, manuscript in
preparation). A & B) Isosmotic removal of aCSF Cl- (0Cl) resulted in CPEC
shrinkage that reversed upon readmission of isosmotic solution (ISO), and
indicated that external Cl- was required for CWV maintenance. A) Volume
recording of a CPEC from a WT that shrank -32.4% compared to a CPEC from a
NKCC1 -/- mouse (B) where the cell shrank -4.8%. C) CWV recovery was
reduced in the presence of 10 µM bumetanide. During the bumetanide-
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insensitive component of the volume recovery (BIC), the volume in this cell only
recovered 1.3%, while most volume was restored during the bumetanidesensitive component of the volume recovery (BSC) after the drug was removed.
D) In the absence of external Na+ there was also incomplete CWV recovery. The
BIC and Na+-independent (SIC) components indicated the expression of
mechanisms other than NKCC1 in this volume recovery. BIC mean rate of
volume recovery was much faster than the BSC mean rate of volume recovery at
8.3% / min vs 2.6% / min, respectively. The Na+-dependent component (SDC) of
the recovery proceeded at a rate that was one order of magnitude faster than in
0Na+ (SIC mean rate of volume recovery was 2.5% / min vs. 30.2% / min during
SDC). Thus, most of the Cl- fluxes were mediated by Na+-dependent and
bumetanide-sensitive mechanisms, most likely NKCC1.
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(SIC) components indicated the expression of mechanisms other than NKCC1 in this
volume recovery. However, most of the water fluxes (and inferred Cl- fluxes) were
mediated by Na+-dependent and bumetanide-sensitive mechanisms, most likely
NKCC1.

Conclusion

The data presented above demonstrate that basal NKCC1-mediated fluxes
are inwardly directed in CPECs. When NKCC1 was genetically ablated in the KO
mouse and/or when NKCC1 was inhibited with bumetanide, CPECs lost CWV due to
an imbalance in the net solute and water fluxes across the cell. Additionally, full
recovery from a loss of cell water and intracellular Cl- required the presence of
external Na+ and was bumetanide sensitive. This supports the hypothesis that
NKCC1 is constitutively active and functions in the maintenance of both normal and
constant CWV in CPECs.
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Chapter 5: Specific Aim 2 Results

The experiments in this chapter focus on answering the following questions:
1) What are the [Na+]i and [Cl-]i of mammalian CPECs?
2) Do the [Na+]i and [Cl-]i change in CPECs from NKCC1 -/-?
3) Can apical NKCC1 act as a sensor and regulator of CSF [K+] in CPECs?
The link between these questions became evident while attempting to create a
predictive model of NKCC1 cotransport in relation to CSF [K+]. At that time, we came
across very different values for the intracellular ion concentrations of CPECs, and
quickly realized the necessity to measure these concentrations ourselves (see next
section). Without these data, it would have been impossible to make our model
realistic. Answering the first question involved using the ion-sensitive dyes ANG-2
and MQAE to determine the intracellular Na+ and Cl- concentrations, respectively. To
answer the second question, we examined the sensitivity of CPECs to small changes
in external [K+] within a physiological plausible range.
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Figure 5.1: Measuring [Na+]i in single CPECs using ANG- 2. Top) Measurement of
basal [Na+]i in a NKCC1 +/+ CPEC loaded with ANG-2. The basal [Na+]i of this
CPEC was 9 mM. After taking the basal [Na+]i measurement, NKATP was
inhibited with ouabain (1 mM) to test that the dye responded to changes in [Na+]i.
In this CPEC, ouabain exposure resulted in an increase in [Na+]i to ~45 mM,
which was reversible upon the removal of ouabain. Bottom Left) Fitting the
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Michaelis-Menton equation to the plot of the relative fluorescence (1-Fo/Ft) of
ANG-2 vs [Na+] provided Kd and Fmax values for each cell. These values were
used to convert fluorescence intensities into [Na+]. Bottom Right) Histogram
showing the distribution of [Na+]i in the 21 individual CPECs. The mean [Na+]i of
CPECs was 8.4 ± 1.0 mM, n = 3 animals.
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Intracellular Na+ and Cl- concentrations of mouse CPECs

Using ANG-2, we found that [Na+]i of WT CPECs was 8.4 ± 1.0 mM (n = 3
animals), as shown in Figure 5.1. This Na+ concentration was closer to the values of
10 –15 mM measured in amphibians (Saito & Wright, 1987; Zeuthen, 1994) using
ion-selective microelectrodes, but differed greatly to the [Na+]i measured by
Johanson and Murphey (1990) and Smith and Johanson (1985) using whole tissue/
flame photometry, or that by Keep et al., (1994) in their calculations to determine
the direction of cotransport. The average values of [Na+]i obtained or assumed by
Johanson, Keep, and coworkers ranged between 30 -48 mM. Our measured [Na+]i
was consistent with [Na+]i measured in a number of epithelial and non-epithelial
cells using fluorescent dyes or microelectrodes (Donoso, Mill, O'Neill, & Eisner,
1992; Rose & Ransom, 1996; Zeuthen, 1978, 1994; Zhao & Muallem, 1995). In
Figure 5.2, a comparison of the ion concentrations presented by Johanson and
Murphey (1990), Keep et al., (1994), Saito and Wright (1987), and our measured
intracellular Na+ and Cl- concentrations was made. We were unable to measure the
[K+]i in CPECs because so far there are no reliable dyes for this cation, so we used an
[K+]i = 110 mM based on the range of values obtained by Zeuthen et al., (1987) using
ion-selective microelectrodes in amphibian CP of 100-120mM (Zeuthen,
Christensen, Baerentsen, & la Cour, 1987).
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measured and reported intracellular ion concentrations
∆μ NKCC1 was calculated using the equation below and reported extracellular and intracellular ion concentrations. Based on
CWV measurements and CSF ion concentrations, we predict [Na+]i must be significantly lower than reported in mammalian CPECs and closer to that measured using ion-selective microelectrodes in amphibian CPECs (Saito & Wright, 1987).
μ = RT • ln
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Figure 5.2: Effect of [Na+]i on the net free energy driving NKCC1 transport in
CPECs. Measurements using the fluorescent indicator dye ANG-2 revealed that
mouse CPECs had an [Na+]i = 8.4 ± 1.0 mM, similar to that of amphibian CPECs,
10.5 mM, measured by Dr. Zeuthen using ion-selective microelectrodes and
reported by Saito & Wright (1987). Using the measured values for [Na+]i and [Cl-]i
in equation 1, we found DµNKCC1 was negative, indicating that under basal
conditions the cotransporter is working in the inward direction.
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Table 5.1: CPEC intracellular ion concentrations used to calculate DµNKCC1.
[Na+]i

[Cl-]i

[K+]i

[Na+]o [Cl-]o

[K+]o

(mM) (mM) (mM) (mM) (mM) (mM)
Johanson & Murphy (1990)

48

65

145

154

128

3

Keep et al., (1994)

30

50

120

150

130

3

Saito & Wright (1987)

10.5

31.6

90

110

89

2

Our Measured Values

8.4

62.1

110*

126

131

3

The top two rows represent values for mammalian CPECs, while Saito & Wright
used amphibian CPECs. The values for [Na+]i reported for mammalian CPEC are
very large compared to the value for amphibian CPEC. *estimate value based on
the range of values obtained by using ion-selective microelectrodes in amphibian
CP of 100 -120 mM (Zeuthen et al., 1987). The same value has been obtained in
glioma cells using the fluorescent indicator PBFI-AM (Zhu et al., 2014).
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Using MQAE we found [Cl-]i of NKCC1 WT CPECs was 62.1 ± 3.5 mM (n = 5
animals), a concentration that was close to that reported for other mammalian CPEC
(Johanson & Murphy, 1990). Both mammalian [Cl-]i measurements were about 1.5X
greater than those of amphibian CPECs using ion-selective microelectrodes, which
were approximately 40 mM (Saito & Wright, 1987; Zeuthen, 1987).
We used the same methodological approach to measure [Na+]i and [Cl-]i in
CPECs from NKCC1 -/- mice. The results show that [Na+]i was 12.2 ± 1.2 mM (n = 3
animals), a value that was not significantly different to that in WT CPECs (p = 0.07).
In contrast, the [Cl-]i of NKCC1 -/- CPECs was significantly less than that of WT cells;
[Cl-]i of NKCC1 -/- CPECs was 31.5 ± 4.8 (n = 7 animals), which was significantly
different (p <0.001) to that of WT (Figure 5.3). This decrease in intracellular [Cl-] by
about -50% is consistent with NKCC1 being a major Cl- uptake system that
maintains [Cl-]i and cell volume at a level needed for the cells to work. Knowing both
the intra- and extracellular [Cl-], it was possible to estimate the chloride equilibrium
potential (ECl) in WT and KO CPECs using equation 5. The ECl was then be compared
to the membrane potential (Em) of -53 mV, a value recorded in rat CPECs (Kotera &
Brown, 1994), to determine whether Cl- was passively distributed across the
membrane or actively maintained above chemical equilibrium in CPECs. The
estimated mean ECl of NKCC1 +/+ CPECs was -19.71 ± 1.4 mV (assuming all the cells
had the same Em, which obviously renders this calculation as a valid, but rough
estimate). All of the WT CPEC had estimated ECl values that were less negative than
expected if Cl- was maintained above electrochemical equilibrium in CPECs. The
estimated mean ECl in NKCC1 -/- CPECs was -38.9 ± 4.2 mV (n= 7 animals), a value
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Figure 5.3: Measuring [Cl-]I in single CPECs. Representative examples of NKCC1
+/+ and NKCC1 -/- Cl- transients that measured the [Cl-]i and ECl of single CPECs
loaded with MQAE. CPECs became depleted of their internal Cl- stores when
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the external Cl- was removed (0Cl-), and were able to recover to initial values
when external Cl- was replaced. The difference between the ISO and 0Clsteady-states (gray arrow) was used to calculate the [Cl-]i. The inset is the
calibration plot of the relative MQAE fluorescence (Fo/Ft) as a function of [Cl-] in
the calibration solutions, and the slope of this relationship is the Stern-Volmer
constant (KSV). Top) Cl- transient from NKCC1 +/+ CPEC. The [Cl-]i measured in
this cell was 62.9 mM, the KSV = 19.7 M-1, and ECl was calculated at -18.9 mV.
Bottom) Cl- transient from NKCC1 -/- CPEC. The [Cl-]i in this was measured to
be 22.9 mM, KSV = 8 M-1, and ECl was calculated at -44.8 mV.

NKCC1 -/-

CPECs had a reduction in [Cl-]i by 50% compared to WT. NKCC1 -/- CPECs also
had a reduced KSV, which may have been a consequence of the reduced CWV,
however further investigation on this matter is necessary.

58

that was more negative than that of the WT, but still more positive than Em by about
10 mV. These estimates must be taken with caution because the actual Em was not
measured in the present study. However, it is worth mentioning that of the 7 NKCC1
-/- animals in this study, 2 had an estimated mean ECl more negative than -50 mV.
Meaning that in some animals, Cl- was passively distributed across the CPEC plasma
membrane.

Testing the sensitivity of NKCC1 in CPECs to small changes in [K+]o.

The net free energy driving NKCC1 depends on the extracellular and
intracellular concentrations of the cotransported ions (Na+, K+, and Cl-), and the
stoichiometry (see equation 1). Equation 1 predicts that relatively modest changes
in [K+]o have a big impact on ΔμNKCC1 (Figure 5.4). Figure 5.4 illustrates how the
[K+]CSF of 2.9 –3 mM resulted in the cotransporter working nearer to its flux reversal
point (FRP), where the chemical potential driving force of NKCC1 (ΔμNKCC1) is equal
to zero, as compared to the more negative value of ΔμNKCC1 when [K+]o is 4.7 –5 mM,
as in the plasma. Specifically, the FRP of NKCC1 in CPECs occurred between 1.4 – 1.6
mM [K+]o when using the measured [Na+]i and [Cl-]i , and the estimate of [K+]i of 110
mM reported by Zeuthen et al., (1987). When [K+]o dropped below the FRP, the
model predicted that NKCC1 would reverse direction and ion cotransport would
occur in the outward mode. We can think of this thermodynamic model in vector
terms, with each point on the graph representing both a direction of cotransport
and magnitude of the driving force. The farther away a point is from zero, the
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greater the driving force of NKCC1 cotransport. Additionally, the curve of ΔμNKCC1 vs
[K+]o became increasingly steep as [K+]o decreased. This is due to the stoichiometry
of NKCC1. Cotransport mediated by NKCC1 requires the binding of 2 Cl-, which
results in the internal and external [Cl-] to be raised to the power of 2 in equation 1.
As [K+]o decreases to 1 mM, the influence of [Cl-]o on NKCC1 transport increases.
When [K+]o becomes less than 1 mM, the product of the denominator in equation 1
approaches zero. A small change in the [K+]o of ± 2 mM K+ with respect to the basal
level of 3 mM, is sufficient to reverse the sign of ΔμNKCC1 indicating a change in the
direction of cotransport. In the experiments that follow, we tested the sensitivity of
dissociated CPECs in vitro to ± 2 mM changes in [K+]o. We used measured changes in
the CWV of CPECs that occurred in response to changes in [K+]o, as an indicator of
the net flux direction and magnitude, and utilized the two-prong approach to NKCC1
transport inactivation as in Chapter 4.
One of the central hypotheses of this work is that apical NKCC1 of CPECs is
highly sensitive to changes in [K+]CSF. This is predictable given that the cotransporter
is in the apical membrane, which is in direct contact with the CSF, and because of the
net free energy driving the cotransporter, as discussed above (equation 1), and the
Km for K+ of NKCC1 (Payne & Forbush, 1995). An isosmotic decrease in [K+]o by 2
mM (i.e., from baseline 3 mM to 1 mM) produced a mean CPEC shrinkage of -11.8 ±
1.7% (n = 11 animals), that proceeded at an initial rate of -12.0 ± 1.4% / min. An
isosmotic increase in [K+]o by 2 mM (i.e., from 3 mM to 5 mM), caused CPECs to
swell by 10.4 ± 1.6% (n = 8 animals), and the initial rate of that swelling was 8.3 ±
1.0% / min. CPECs from NKCC1 KO mice had no change in CWV in response to
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Figure 5.4: Modeling the FRP of NKCC1 as a function of [K+]o in CSF and artificial CSF (aCSF). Plot of Dµ of
NKCC1 as a function of [K+]o in CSF (red) or in aCSF (black). The NKCC1 mediated fluxes reverse when Dµ=0 (FRP),
which occurs in this model when [K+]o is 1.4 mM (CSF) or 1.6 mM (aCSF). This indicates that under physiological [K+]o
(2.9-3 mM) NKCC1 works in the inward mode, near thermodynamic equilibrium. Dµ is calculated at T= 295 K for aCSF
and T= 310 K for CSF. The FRP is unchanged for temperatures between 295 -310 K.
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dG (J/mol)

4

Both direction and magnitude of the overall net free energy driving NKCC1 transport (Δμ) can be predicted using
the ion concentrations shown in the table below. For an
electroneutral stoichiometry of 1Na+:1K+:2Cl-,

± 2 mM changes in [K+]o, which indicated that they lost this “K+-sensitivity.”
Specifically, after 5 minutes of exposure to 1 mM K+ and 5 mM K+, the mean CWV
change in NKCC1 -/-cells was within the noise level of < 1% (n = 3 animals for each).
Figure 5.5 provides a comparison between the traces obtained from single WT
CPECs vs NKCC1 -/- CPECs. There was a striking difference in the volume response
to changes in [K+]o between the two representative cells. In the top trace, the WT
CPEC showed a robust shrinkage in response to lowering the [K+]o just 2 mM, that
reversed upon exposure to baseline 3 mM K+. The cells swelled in response to
increasing [K+]o from 3 mM to 5 mM. These responses were absent in NKCC1 -/CPECs, as shown in the lower panel of Fig. 5.5. To further prove that the previous
results were due to specific inactivation of NKCC1-mediated fluxes and not to some
unknown change related to the genetic mutant, such as a change in the location or a
functional alteration of other membrane proteins (e.g., NKATP or aquaporin 1
(AQP1)), the changes in CPE CWV in response to ± 2 mM K+ were repeated in cells
from NKCC1 +/+ in the presence of 10 μM bumetanide, a concentration expected to
block NKCC1 (Alvarez-Leefmans, 2012; Russell, 2000). As illustrated in Figure 5.6,
CPECs responded to two sequential changes in external [K+]. Pharmacologic
inhibition of NKCC1 with 10 μM bumetanide resulted in CPEC shrinkage, as
expected from halting constitutively active NKCC1, that blocked the “sensitivity” to
the changes in [K+]o which was clearly mediated by NKCC1. Bumetanide produced
CPEC shrinkage and blocked the cell’s ability to swell in response to a second
exposure of 5 mM K+ (Figure 5.6C). Similarly, in the presence of bumetanide CPEC
shrinkage when [K+]o was decreased to 1 mM K+ did not occur (Fig. 5.6D). However,
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Figure 5.5: Comparison of the changes in relative cell volume of CPECs in
response to various [K+]o in cells dissociated from NKCC1 +/+ and NKCC1 /- animals. Top trace illustrates the CPEC volume sensitivity to ± 2 mM changes
in [K+]o, and the bottom trace the experiment was repeated in an NKCC1 -/CPEC. Top) WT CPEC shrank by -20.6% when K+ was lowered to 1 mM, and
swelled 10.0% above its basal volume when K+ was increased to 5 mM. Bottom)
NKCC1 -/- CPEC does not respond to± 2 mM changes in [K+]o. Both cells were
able to respond to the ± 10% anisosmotic calibrations. Thus, in the absence of
NKCC1, CPECs lose the ability to respond to ± 2 mM changes in external [K+].
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Figure 5.6. CPEC sensitivity to changes in [K+]o was blocked by
bumetanide. A & B) Isosmotic changes in cell water volume induced in CPECs
by altering [K+]o ± 2 mM K+ were blocked by bumetanide. (A) CWV changes in
response to two sequential 5K pulses (from 3 to 5 mM K+) (B) Similar to A, but
the sequential pulses were 1K (from 3 to 1 mM K+). There was a slight decrease
in the amplitude of the second K+ pulse compared to the first, but the effect of the
second K+ pulse was reproducible and of sufficient amplitude to be used as test
pulse in the experiments shown in the second part of this figure to probe the
effect of bumetanide. In trace A, the first 5 mM K+ pulse produced a swelling of
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8.0% compared to a swelling of 6.8% in the second pulse. Differences between
the first and second 1 mM K+ pulses (B) were larger. The shrinkage during the
first 1 mM K+ pulse was -12.4% verses -7.9% during the second 1 mM K+ pulse.
C & D) Inhibition of NKCC1 with 10 μM bumetanide resulted in CPEC shrinkage
and loss of the response to small changes in [K+]o. Following a control pulse of 5
mM K+ (C) or 1 mM K+ (D), the application of bumetanide produced CPEC
shrinkage and blocked the cell’s ability to response to a second ± 2 mM change
in [K+]o.
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Figure 5.7: Cell water volume recovery following 1 mM K+ isosmotic
shrinkage was bumetanide-sensitive in CPECs from NKCC1 +/+. CWV
recovery from shrinkage produced by exposure to 1K was blunted in the
presence of 10 µM bumetanide. However, there was a small bumetanideinsensitive component (BIC) of the recovery. During the BIC, the volume in this
cell recovered from -7.2 to -5.1 %, and the remaining volume recovery occurred
during the relative bumetanide-sensitive component (rBSC) after the drug was
removed. The BIC indicates the possibility of mechanisms other than NKCC1 in
this volume recovery. BIC mean rate of volume recovery is 0.71 % / min
compared to the rBSC mean rate of volume recovery at 1.3 % / min.
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CPECs presented a modest volume recovery from shrinkage in the presence of
bumetanide to a mean volume of -5.2 ± 0.1% (n = 3 animals) (Figure 5.7). The
bumetanide-insensitive (BIC) component of the CWV suggested either incomplete
block of NKCC1, or the expression of mechanisms other than NKCC1 in this volume
recovery. BIC mean rate of volume recovery was the same as the relative
bumetanide-sensitive component (rBSC) mean rate of volume recovery at
1.2%/min, indicating that possibly the same mechanism was responsible for both
components of the recovery. These results are consistent with our data using NKCC1
KO mice, and reveal that the [K+]o sensitivity of CPECs was dependent on NKCC1mediated fluxes.

Testing the sensitivity of NKCC1 to various [K+]o with solutions buffered with
CO2/HCO-3

The previous experiments were performed using HEPES buffered solutions
equilibrated in air. Under these conditions, atmospheric CO2 is able to dissolve into
the solutions, leading to CO2 hydration and consequent formation of H2CO3, which
dissociates to form H+ and HCO3- (Praetorius & Damkier, 2017). Further, cell
metabolism results in the production of intracellular CO2 which reacts with
intracellular water also forming HCO3-. Given the presence of extracellular and
intracellular membrane bound carbonic anhydrases (CA) in CPECs (reviewed in
Praetorius & Damkier, 2017), the CO2 hydration reactions are catalyzed both in the
intra- and extra-cellular membrane domains. Thus, HEPES solutions equilibrated
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with air do have sufficient bicarbonate to drive bicarbonate-dependent
transporters. This effect is enhanced because the major bicarbonate transporters
physically or functionally interact with the various intra- or extra-cellular CAs
isoforms, forming supramolecular complexes known as “metabolons” (Deitmer &
Becker, 2013; Deitmer, Theparambil, Ruminot, & Becker, 2014; McMurtrie et al.,
2004). CPECs have a high concentration of CA’s that catalyze the hydration of CO2
thereby forming H+ and HCO3- (Fisher & Copenhaver, 1959; Giacobini, 1961, 1962;
Maren, 1967; Masuzawa, Shimabukuro, Sato, & Saito, 1981). A reason for
performing experiments using HEPES-buffered solutions equilibrated with air is
that it is easier to maintain a constant pH compared to CO2/HCO3-, when running the
solutions through perfusion lines. Further, experiments using HCO3- buffered aCSF
showed that WT CPECs responded similarly to changes in [K+]o in either HEPES or
HCO3- buffered solutions (Figure 5.8). In HCO3- buffered solutions the mean
shrinkage in response to 1 mM K+ was -13.1 ± 2.3 % (n = 4 animals) and the mean
swelling in response to 5 mM K+ was 16.6 ± 2.9 % (n = 4 animals), with p = 0.69 and
0.07, respectively, when compared to their corresponding responses in HEPES
buffered solutions. Table 5.2 summarizes the data below. It is important to mention
that K+ induced responses showed considerable variability between cells, possibly
due to variations in the content of intracellular ions affecting NKCC1 transport.
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Figure 5.8: CPEC K+ sensitivity was unchanged in the presence of added
HCO3- to the bathing solutions. Two representative cells showing the CWV
response to ± 2 mM K+ in CO2/ HCO3- buffered bathing solutions. No significant
differences were found between the K+ sensitivity of CPECs in bicarbonate
buffered solutions vs HEPES buffered solutions. Top) A WT CPEC was exposed
to 1 mM K+ and this particular cell shrank -18.1 %. Bottom) This WT CPEC was
exposed to 5 mM K+ and swelled 19.1 %.
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Table 5.2: Comparing the changes in CWV in response to ± 2 mM K+ when the
bathing solutions are buffered with HEPES vs CO2/HCO3-.

Buffer 1 mM K+

5 mM K+

DVolume

DVolume

HEPES -11.8 ± 1.7%
n = 11 animals
CO2/HCO3- -13.1 ± 2.3 %
n = 4 animals
Significance P = 0.69

10.4 ± 1.6%
n = 8 animals
16.6 ± 2.9 %
n = 4 animals
P =0.07

A comparison of the K+-induced changes in CWV in differently buffered bathing
solutions.
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Conclusion
CPECs had an [Na+]i = 8.4 mM and an [Cl-]i = 62.1 mM. These concentrations
support the hypothesis that in CPECs NKCC1 functions near to its FRP. CPECs were
exquisitely sensitive to small changes in [K+]o in the physiological range of ± 2 mM.
In the absence of NKCC1-mediated fluxes, either by pharmacological inhibition or
genetic ablation using the NKCC1 -/- mouse, CPECs lost this [K+]o sensitivity. This
loss in sensitivity was not the result of altered NKATP or AQP1 expression on the
apical membrane of NKCC1 -/- CPECs (see Appendix A). Thus, we propose that the
CPECs use NKCC1 as a sensor and regulator of CSF [K+].
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Chapter 6: Discussion

The results in this dissertation contribute to elucidating the function of the
apical NKCC1 cotransporter in CPECs, with a focus on determining 1) the direction
of NKCC1 cotransport under basal conditions; and 2) whether NKCC1 works near to
its FRP, thus permitting it to function as a sensor and regulator of CSF [K+]. These
data include a three-pronged approach to NKCC1 inactivation, utilizing NKCC1 -/mouse, pharmacological inhibition of NKCC1 with bumetanide, and ion-substitution
experiments.
NKCC1 inactivation by either genetic ablation or pharmacological inhibition
reduces CPEC water volume by ~16% (Figure 4.2, 4.3, and Table 4.1). Ionsubstitution experiments demonstrate that maintenance of normal CPEC water
volume requires the presence of external Cl- and Na+, and is bumetanide-sensitive
(Fig. 4.4). These data prove that NKCC1 is constitutively active and inwardly
directed in CPECs under basal physiological conditions, solving a long-standing
controversy in the field. Further, the results of the present study establish that a
critical function of NKCC1 in CPECs is the maintenance of both normal and constant
CWV, that we propose is needed for CSF secretion.
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Reported [Na+]i of CPECs range from 10 –15 mM in amphibians, and 30 –50 mM
in mammals (Figure 5.2 and Table 5.1) (Johanson & Murphy, 1990; Keep et al., 1994;
Saito & Wright, 1987; Zeuthen et al., 1987). Using the non-invasive Na+-indicator,
ANG-2, the [Na+]i measurement of mouse CPECs is 8.4 ± 1.0 mM (Figure 5.1), a value
much less than is reported for mammalian CPECs (30 -50 mM) from whole tissue,
but closer to the 10 –15 mM measured in single CPECs of amphibian using ionselective microelectrodes. The ANG-2 [Na+]i measurements require the calibration
of every cell in order to determine the individual Kd of each cell. The verifies that
the calibration solutions of permeabilized cells do not give spurious values due to
changes in cell volume, a very important control for a single excitation/emission
dye.
NKCC1 -/- CPECs have ~50% reduction in [Cl-]i (31.5 ± 4.8, n = 7 animals, p
<0.001) compared to WT (62.1 ± 3.5 mM, n = 5 animals), and in both WT and KO
CPECs, intracellular Cl- is maintained above chemical equilibrium (Figure 5.3).
Estimates of ECl were made using measured [Cl-]i but assuming a constant Em, and
are consequently considered preliminary. Nevertheless, the results suggest that in
the absence of NKCC1, these cells are endowed with other Cl- uptake mechanisms, a
situation similar to that reported for NKCC1-/- olfactory neurons and DRG neurons
(Alvarez-Leefmans & Mao, 2015; Nickell, Kleene, & Kleene, 2007).
Using these measurements for intracellular [Na+] and [Cl-], a model of the net
free energy driving NKCC1 cotransport can be created (Figure 5.4). This model is
consistent with the hypothesis that NKCC1 is working in the inward direction and
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relatively near to thermodynamic equilibrium, or its FRP, when [K+]o is 3 mM, which
is the physiological concentration in CSF. Since NKCC1-mediated fluxes are tightly
linked to water fluxes (Figure 2.2), changes in CWV act as a surrogate for measuring
NKCC1-mediated K+ fluxes in CPECs (Alvarez-Leefmans, 2012; Hamann et al., 2005;
Hamann et al., 2010; Rocha-Gonzalez et al., 2008; Zeuthen & Macaulay, 2012).
Results show that CPECs are exquisitely sensitive to changes in [K+]o; varying [K+]o
as little as ± 2 mM, keeping the osmolality constant i.e., isosmotic with respect to the
control solution, is sufficient to produce changes in CWV of ± 10 % or greater
(Figure 5.5), indicating that NKCC1 reverses transport direction. Although this
reversibility is predicted on thermodynamic grounds (Alvarez-Leefmans, 2012;
Russell, 2000), to our knowledge, this is the first demonstration of this property of
NKCC1. That the changes in CWV are specifically mediated by NKCC1, is evident
given that NKCC1 -/- CPECs do not respond these changes in [K+]o, thus these cells
lose their external “K+ sensitivity”. As expected from the NKCC1 -/- experiments,
pharmacologic inhibition of NKCC1 with 10 µM bumetanide blocks the response to
changing [K+]o in WT CPECs. These results not only prove the reversibility of NKCC1
transport, but strongly suggest that NKCC1 can function as a sensor and regulator of
[K+]o in CPECs.

The direction of NKCC1 cotransport in CPECs

To understand the functional role of apical NKCC1 in CPECs, it is critical to
determine the direction of NKCC1 transport under basal physiological conditions.
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Outwardly directed NKCC1 transport, operating in the net efflux mode, would
function solely as a CSF secretion mechanism. Conversely, an inwardly directed
NKCC1 transport would have an absorptive function and contribute to maintenance
of CWV. The direction of NKCC1 cotransport has been debated since it was first
hypothesized that the cotransporter is located to the apical membrane of CPECs by
Keep et al., (1994), which was later demonstrated by Plotkin et al., (1997) using
immunofluorescence microscopy with NKCC1 specific antibodies (Plotkin et al.,
1997). The apical location generates a debate because NKCC1 expression usually
occurs in the basolateral membrane of secretory epithelia. In 1998, Wu et al.
provided evidence in individual CPECs that contradicts the claims made by Keep et
al., (1994), and supports NKCC1 functioning in the inward direction (Wu et al.,
1998). The present findings confirm and extend those of Wu and colleagues.
CPECs maintain normal cell volume through a balance of net solute and
water influx to efflux. As illustrated in Figure 6.1, basolateral Na+ and HCO3- influx
occurs through the Na+/ HCO3- Cl- exchanger (NBCE) and the electroneutral
Na+/HCO3- cotransporter (NBCn1), and Cl- uptake occurs via the anion exchanger 2
(AE2) (Praetorius & Damkier, 2017). There is basolateral efflux of HCO3- via AE2 and
Cl- via NCBE, with the additional K-Cl efflux through KCC3a (Praetorius & Damkier,
2017). On the apical membrane, K+ influx occurs mostly through NKATP and NKCC1.
Apical Na+ influx by the Na+/ H+ exchanger (NHE1), and Na+ and Cl- influx through
NKCC1 (Praetorius & Damkier, 2017). Both outward and inward rectifying K+
channels (Kv 1.1, Kv 1.3, Kir 7.1, KCNQ1, and KCNE2) are present on the apical
membrane to facilitate K+ recycling to the lumen, in addition to volume activated K75

Cl- efflux through KCC4 (Praetorius & Damkier, 2017). While most of the Cl- efflux is
carried by the volume activated and inward rectifying Cl- channels (Clir and VRAC)
(Praetorius & Damkier, 2017). Apical Na+ efflux by NKATP and the electrogenic
Na+/ HCO3- cotransporter (NBCe2), along with HCO3- efflux via NBCe2 and H+ efflux
via NHE1 (Praetorius & Damkier, 2017). Carbonic anhydrases are located on the
basolateral membrane (CAXII & CAIX) and in the cytosol (CAII), and aquaporin 1
(AQP1) is expressed on the apical membrane (Praetorius & Damkier, 2017). By
inactivating NKCC1 on the apical membrane, there is a decrease in Na+, K+, and Clinflux, along with associated water. This imbalance in the net solute and water
fluxes results in CPECs shrinking until the net solute and water efflux is once again
balanced with the net influx, and the new steady-state is obtained. Measurements of
CSA of freshly dissociated CPECs from NKCC1 -/- mice shows they are ~18 µm2
smaller than those from WT (Figure 4.2); additionally, inhibiting NKCC1-mediated
fluxes with bumetanide (10 µM) causes a decrease in CPEC water volume by -15.9 ±
9.1%, (n = 3 animals) (Figure 4.3). Using live-cell imaging microscopy the research
presented here extends the results of Wu et al., (1998) by resolving the precise
change in CWV that occurs when NKCC1 is inhibited with bumetanide. Further,
these measurements include the CSA of NKCC1 -/- CPECs (137 ± 4.9 µm2, n = 22
animals), and by extrapolating the radii and treating the cells as hemispherical
domes, NKCC1 -/- CPECs have a predicted volume reduction of ~16% (Table 4.1). In
comparison with the -15.9% mean CWV reduction observed in bumetanide exposed
WT CPECs, one can conclude a near complete inhibition of NKCC1 occurs using 10
µM bumetanide. Wu et al., (1998) used bumetanide concentrations as high as 100
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µM to ensure complete inhibition of NKCC1, which can lead to non-specific
inhibition of other cation cotransporters expressed in CPECs such as apical KCC4
and basolateral KCC3a (Alvarez-Leefmans, 2012).
NKCC1-mediated ion and associated water fluxes are essential contributors
to CWV regulation in both polarized and symmetrical cell types (Hamann et al.,
2010; Rocha-Gonzalez et al., 2008; Russell, 2000). The findings presented here
demonstrate that NKCC1-mediated fluxes not only contribute to maintaining the
normal and constant CWV of CPECS, but also support the hypothesis that under
basal conditions NKCC1 is constitutively active in CPECs. When a cotransporter is
constitutively active, it is always “on”, constantly working. Almost immediately
upon the application of 10 µM bumetanide WT CPECs begin to shrink (Figure 4.3),
indicating that NKCC1 is actively co-transporting in the inward direction under
basal isosmotic conditions. This response is in contrast to what is found some other
cell types, including human pigmented retinal epithelial cells and dorsal root
ganglion cells (Hamann et al., 2010; Rocha-Gonzalez et al., 2008; Russell, 2000).
Thus, NKCC1 is constitutively active in CPECs. Evidence of a constitutively active
NKCC1 suggests that in certain cell types, such as CPECs, the cotransporter has a
background or persistent phosphorylation state that contributes to cell volume
maintenance. In Cl- transporting secretory epithelial cells of exocrine glands (e.g.,
salivary, lacrimal, airway epithelium, intestinal crypts, and corneal epithelium), the
direction of basolateral NKCC1 cotransport occurs in the same direction as epithelial
secretion and NKCC1 participates in trans-cellular Cl- transport and CWV
maintenance (Haas & Forbush, 2000; Hamann et al., 2010; Nakamoto et al., 2007;
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Silva et al., 1977; Walcott, Birzgalis, Moore, & Brink, 2005). Interestingly, apical
NKCC1 cotransports in the direction opposite to that expected for epithelial
secretion in CPECs. In the absence of external Cl-, CPECs experienced a large
decrease in CWV, -20.3 ± 1.8% (n = 10 animals), presumably due to cell Cl- depletion
(Figure 4.4A). NKCC1 -/- CPECs responded to external Cl- removal with a more
modest decrease in CWV of -7.7 ± 2.1% (n = 4 animals) (Figure 4.4B), which
supports NKCC1 -/- CPECs having less CWV than WT (because they have
significantly less Cl- and K+). The recovery of CWV that followed Cl- depletion was 55
- 78 % (n = 3 animals) Na+-dependent and 70 – 85 % (n = 3 animals) bumetanidesensitive in CPECs (Figure 4.4C, D, and APPENDIX B), strengthening the notion that
NKCC1 contributes to cell Cl-, water accumulation, and CWV maintenance and it
behaves as an absorbing epithelium. Taken together, this evidence supports the
hypothesis of Specific Aim 1: A function of NKCC1 in CPECs is the maintenance of
both normal and constant CWV. Under physiological conditions NKCC1 is
constitutively active, inwardly transporting ions and associated water.

Measurements of [Cl-]i in single CPECS

Inhibiting NKCC1 in CPECs with bumetanide is shown to reduce both Cluptake by the cells and Cl- efflux into the CSF (Johanson et al., 1990; Johnson, Singer,
Hoop, & Kazemi, 1987; Preston et al., 1993). NKCC1 -/- CPECs shrink 62% less, p <
0.01, in response to Cl- depletion compared to WT CPECs (Figure 4.4 A-B). These
results suggest NKCC1 -/- CPECs have less intracellular [Cl-] than WT cells. To test
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this hypothesis, we measured the [Cl-]i of individual CPECs isolated from both WT
and NKCC1 -/- mice using the Cl- indicator MQAE, and find that NKCC1 -/- CPECs
have approximately half the [Cl-]i as WT CPECs, p < 0.001 (Figure 5.3). CPECs from
WT have a mean [Cl-]i equal to 62.1 ± 3.5 mM (n = 5 animals) and NKCC1 -/- CPECs
have a mean [Cl-]i of 31.5 ± 4.8 (n = 7 animals). This decrease in [Cl-]i of NKCC1 -/CPECs is in agreement with the findings of Johanson et al., (1990) who report that
(10 –100 µM) bumetanide reduces CPEC Cl- uptake by ~45% (Johanson et al., 1990).
They conclude that bumetanide and DIDS (4,4-diisothiocyanatostilbene-2,2'disulfonic acid, an inhibitor of Cl-/HCO3- exchange) equally contribute >90% of Cluptake in CPECs (Johanson et al., 1990). Thus, although NKCC1 is the main Clloader, it is not the only Cl- loader. For instance, anion exchangers known to be
expressed in CPECs (Lindsey et al., 1990; Wu et al., 1998) may contribute to uphill
intracellular Cl- accumulation.
There are three reported values of CPEC Em: Rabbit CPEC have a Em of -64 mV
across the ventricular membrane and an Em of -50 mV across the basolateral
membrane (Welch & Sadler, 1965); bullfrog CPECs have a Em of -47 mV when [K+]o =
2 mM (Zeuthen & Wright, 1981); and rat CPECs have an Em of -53 mV (Kotera &
Brown, 1994). We chose Em = -53 mV, measured in rat CPECs (Kotera & Brown,
1994) to calculate ECl from our measurements of [Cl-]i. The mean estimate ECl of
NKCC1 +/+ CPECs is about -19.71 ± 1.4 mV, which is more depolarized (less
negative) than the reported Em of -53 mV, suggesting that Cl- is maintained above
electrochemical equilibrium in CPECs. The difference between ECl –Em (i.e., the
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driving force for Cl-) is ~33 mV. The mean ECl in NKCC1 -/- CPECs is -38.9 ± 4.2 mV
(n= 7 animals), therefore [Cl-]i appears to be maintained above equilibrium in
NKCC1 KO cells as well; but the difference ECl –Em is about 13 mV, one third of that
estimated in WT cells. Although these are rough estimates, given that we did not
measure Em, they suggest that that NKCC1 -/- CPECs have a mechanism of Cl- uptake
other than NKCC1. Whether or not this mechanism is expressed in the NKCC1 -/due to a compensatory change remains to be determined. In their most recent
review, Praetorius and Damkier propose that the two primary Cl- uptake paths in
CPECs are apical NKCC1 and basolateral anion exchanger 2 (AE2) (Praetorius &
Damkier, 2017), so this would point to AE2 being the other Cl- uptake mechanism
observed in the NKCC1 -/-.
Assuming that the hypothesis of Praetorius and Damkier (2017) is correct,
then CPECs uptake Cl- on both the apical and basolateral membranes (Figure 6.1).
AE2 interacts with plasma membrane bound carbonic anhydrases, and AE2 activity
is affected by the [HCO3-] localized near the basolateral membrane (Jeong & Hong,
2016). NKCC1 activity is regulated by the phosphorylation of SPAK, which is
abundantly expressed in the apical membrane of CPECs (Piechotta, Lu, & Delpire,
2002). SPAK phosphorylation occurs by phosphorylated WNK kinases, and Cl- can
competitively bind to the catalytic domain of WNKs to inhibit their autophosphorylation, and consequently inhibit WNK kinase activity (Piala et al., 2014;
Shekarabi et al., 2017). There are four WNKs (WNK1 – 4) which are believed to act
as [Cl-]i and/ or volume sensors that can subsequently modulate the activity of the
slc12 family of cation-chloride cotransporters (Gagnon & Delpire, 2012; Hadchouel,
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Ellison, & Gamba, 2016; Mercado et al., 2016; Piala et al., 2014; Shekarabi et al.,
2017; Terker et al., 2016). In the kidney, Terker and colleagues (2016) find that
WNK4 is inhibited when [Cl-]i is 0 -40 mM, WNK1 is inhibited when [Cl-]i is 60 – 150
mM, and WNK3 is inhibited when [Cl-]i is 100 -150 mM (Terker et al., 2016). WNK2
is not included in this list because it is only found in the brain (Terker et al., 2016),
and it is not currently known if WNK2 kinase is expressed in CPECs. Given the CPEC
[Cl-]i of 62 mM, one would hypothesize that WNK1 and WNK3 could control the setpoint for NKCC1-mediated Cl- uptake and KCC3-mediate K-Cl efflux, since WNK1 and
WNK3 are known to interact with both NKCC1 and KCC3 (Hadchouel et al., 2016).
Additionally, changes in [K+]o lead to changes in Cl- efflux and [Cl-]i, which can
modulate the phosphorylation of WNKs (Shekarabi et al., 2017), supporting NKCC1
functioning as [K+]o regulator.

Measured [Na+]i in single CPECs

Keep et al., (1994) hypothesize that NKCC1 works in the outward under basal
conditions, but near to its FRP, when [Na+]i is estimated at ~30 mM (Figure 5.2)
(Keep et al., 1994). Wu et al., (1998) estimate a similar value of 32.5 mM using
“volume calculations”, but it is unclear how the value of 32.5 mM is obtained. Smith
and Johanson (1985) report that CPEC [Na+]i = 34 –52 mM and Amin et al., (2009)
report a value of 35 mM, it should be noted that both measurements were taken
using pieces of choroid plexus tissue, Smith and Johanson use flame photometry
and Amin et al. use Sodium Green fluorescence of choroidal epithelia containing
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several cells (Amin et al., 2009; Smith & Johanson, 1985). As pointed out by Minta
and Tsein (1989), measuring [Na+]i using methods that measure the Na+ content in
whole tissue will produce erroneously high [Na+], because 1) both intracellular and
extracellular fluid is present in whole tissue making it difficult to assess the exact
value of extra and intracellular water, particularly in a tissue composed of many cell
types like the CP; and 2) methods such as flame photometry measure the total [Na+],
i.e., free plus bound, a value that is greater than the intracellular concentration of
free Na+ (Minta & Tsien, 1989). The major downside to the methods employed by
Johanson’s group is that they use an estimate of percent cell water (Murphy &
Johanson, 1990; Smith & Johanson, 1985) and cannot accurately determine the ratio
of bound vs free Na+ in their measurements, nor can they differentiate between
intra- vs extracellular Na+ in the whole tissue. Similarly, Amin et al., (2009) loaded
pieces of choroid plexus tissue with Sodium Green to obtain the [Na+] of the
epithelium and assume its equivalence to CPEC [Na+]i without controlling for the
presence extracellular fluid or the vasculature.
Using the recently developed Asante Natrium Green 2 indicator from
TEFLabs, Inc., we successfully performed the first [Na+]i measurements in individual
mammalian CPECs. Our measurement of free intracellular [Na+]i in CPECs is 8.4 ±
1.0 mM (n = 3 animals) under basal conditions (Figure 5.1). With this [Na+]i the net
free energy driving NKCC1 transport is inwardly directed in CPECs (Figure 5.2).
Additionally, there is no significant difference between the [Na+]i of WT verses
NKCC1 -/- CPECs (12.2 ± 1.2 mM, n = 3 animals, p = 0.07).
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Figure 6.1: Proposed model of NKCC1 function in CPECs under basal
conditions. CPECs not only secrete CSF but also regulate CSF [K+] using
NKCC1. This homeostatic mechanism is crucial for normal brain function
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because K+ freely diffuses between CSF and interstitial brain fluid. Modest
elevations in CSF [K+] increases net inward ion and water transport mediated by
NKCC1. CSF K+ is taken up into CPECs via NKCC1 & NKATP and either exits
through basolateral KCC3a or is recycled back into the lumen by K+ channels
(Brown et al., 2004; Praetorius & Damkier, 2017). Na+ is recycled by the apical
NKATP, and Cl- is partly recycled via apical Cl- channels and KCCs. Apical KCC4
is only activated upon osmotic cell swelling, whereas basolateral KCC3a is
constitutively active (Alvarez-Leefmans, 2012). This model is consistent with the
notion that apical NKCC1 plays a key role in the reabsorption of K+ from CSF to
blood and in the regulation of brain extracellular [K+].
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NKCC1 functions as a sensor and regulator of CSF [K+]

It is known that CSF K+ is tightly regulated given its constant concentration in
spite of variations in plasma and intraventricular K+ (Ames et al., 1965; Bekaert &
Demeester, 1954; Bradbury & Kleeman, 1967; Cserr, 1965; Husted & Reed, 1976).
This K+ regulation occurs independently and in parallel to CSF secretion (Ames et al.,
1965; Cserr, 1965; Husted & Reed, 1976). CPECs actively uptake K+ through the
combined actions of NKATP and NKCC1, both located on the apical membrane (see
Figure 6.1) (Bairamian et al., 1991; Parmelee & Johanson, 1989; Saito & Wright,
1987; Wu et al., 1998). Husted and Reed (1976) propose the existence of a
mechanism in the CP that is capable of regulating CSF [K+]. This mechanism enables
CPECs to substantially decrease the amount of K+ secreted when CSF K+ is high (6.56
mEq. /l), and also slightly increase the amount of K+ secreted when CSF K+ is very
low (0.15 mEq. /l) (Husted & Reed, 1976). However, the identity of this CSF [K+]
regulation mechanism remained to be determined. Our results demonstrate that
freshly dissociated CPECs are exquisitely sensitive to small changes in [K+]o, and
CPECs lose this K+ sensitivity when NKCC1-mediated fluxes are removed by either
pharmacological inhibition or genetic ablation. By modeling the net free energy
driving NKCC1 transport (DµNKCC1) with respect to [K+]o, we find DµNKCC1 to be
negative. Thus, apical NKCC1 works near to its FRP for basal K+ (2.9 mM) but in the
net inward mode, FRP occurs [K+]o » 1.4 -1.6 mM, in CPECs (Figure 5.4). NKCC1 has
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a Km for K+ of 2.7 mM (Payne & Forbush, 1995), thus DµNKCC1 is in the steep part of
the relation in the range near basal [K+]o (Figure 5.4).
Using the model as our guide, we tested the CPEC sensitivity to ± 2 mM K+
with respect to baseline K+ (3 mM), and keeping the osmolality of the solutions
constant (Figure 5.5). When we increase [K+]o from 3 to 5 mM CPECs swell,
increasing their volume by 10.4 ± 1.6% (n = 8 animals). When we decrease [K+]o
from 3 to 1mM CPECs shrink, decreasing their volume by -11.8 ± 1.7% (n = 11
animals). When we repeat these experiments using NKCC1 -/- CPECs, there is no
statistically significant response to either 1 or 5 mM K+ (Figure 5.5). Similarly, WT
CPECs lose their ability to respond to ± 2 mM changes in [K+]o when NKCC1 activity
is blocked with 10 µM bumetanide (Figure 5.6). CPECs maintain HCO3- above
chemical equilibrium, and HCO3- is important for CSF secretion as inhibiting
carbonic anhydrase (CA) decreases the rate of CSF production by 30 –80 % (Saito &
Wright, 1983, 1984; Vogh & Langham, 1981). Cl-/HCO3- exchange (AE2) is
modulated by plasma membrane bound CA, therefore inhibiting HCO3- production
decreases Cl- uptake on the basolateral membrane (Jeong & Hong, 2016). The
physiological saline solutions used in our experiments are buffered with HEPES and
equilibrated with air. Atmospheric CO2 is able to dissolve into the solutions where it
can readily enter the cell and convert to HCO3- by carbonic anhydrases present
inside the cell and on the plasma membrane (Wright, 1978). To test the hypothesis
that using HEPES buffered solutions does not alter the ability of CPECs to respond to
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changes in [K+]o, the K+ experiments are repeated using CO2/HCO3- buffered saline
solutions.
In the presence of added HCO3- the CWV responses to ± 2 mM [K+]o are
slightly larger (Table 5.2) but not statistically different. During exposure to 1 mM K+
CPECs shrink -13.1 ± 2.3 % (n = 4 animals), and during exposure to 5 mM K+ CPECs
swell 16.6 ± 2.9 % (n = 4 animals). A t-test finds no difference in the 1 mM K+
responses between either buffer, p = 0.69, and no significant difference in the 5 mM
K+ responses, p = 0.07. Altogether, these results suggests that NKCC1 is the K+
sensor described by Husted and Reed (1976) and supports the hypothesis of
Specific Aim 2: NKCC1 is working near to its chemical equilibrium in CPECs,
therefore small changes in [K+]o are sufficient to alter both the direction and
magnitude of NKCC1-mediated ion and associated water fluxes.
In summary, on the apical membrane of CPECs, NKATP and NKCC1 work in
concert to maintain the low CSF K+ concentration (Figure 6.1). However, NKATP
activity alone cannot account for the CSF K+ sensing and regulating abilities of
CPECs. NKATPa1b1/b2 has a high affinity for K+, bring in two K+ ions per cycle with
a Km for external K+ of 0.92 –1.16 mM; whereas NKCC1 has a lower affinity for
external K+, Km » 2.7mM, and uptakes one K+ ion along with a Na+ and two Cl- ions
(Brown et al., 2004; Crambert et al., 2000; Payne & Forbush, 1995; Russell, 2000;
Watts et al., 1991). So, when CSF [K+] is ~ 3 mM, NKATP is transporting more K+ into
the CPECs than NKCC1, but NKCC1 has a greater response rate to fluctuations in CSF
[K+]. Together, NKATP and NKCC1 bring in the K+ and Cl- that is required for
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basolateral K-Cl efflux via KCC3a, the sole K+ transporter mechanism on the
basolateral membrane of CPECs known thus far (Praetorius & Damkier, 2017).
NKATP and NKCC1 may also work in concert to regulate CPEC Na+ secretion, with
NKATP acting as the major Na+ secretion mechanism and Na+ efflux regulation
occurring through the inward transport of NKCC1 (Gagnon & Delpire, 2012). Both
[K+]o and [Na+]i are limited in their respective compartments and prone to
fluctuations that can subsequently alter the direction of net ion and associated
water fluxes mediated by NKCC1. Increases in [Na+]i occur with increases in [HCO3-]i
(Zeuthen & Wright, 1981), and fluctuations in the intracellular ion concentrations
may occur during normal CSF secretion. Figure 6.2 illustrates how both [K+]o and
[Na+]i impact the direction of NKCC1 cotransport in CPECs. The graph illustrates
that both low [Na+]i and high [K+]o promote inwardly directed NKCC1 cotransport in
CPECs. In the physiological range, when [K+]o is 2 – 4 mM and [Na+]i is 10 – 20 mM,
DµNKCC1 is working very near to its FRP and has the ability to reverse the direction of
transport outwards if either [Na+]i becomes too high or [K+]o becomes too low.
Therefore, the [Na+]i that is maintained by NKATP can influence the FRP of NKCC1
with respect to [K+]o and can modulate DµNKCC1. The NKATP Na+ efflux is a major
driver of CSF secretion, as ouabain reduces CSF production, and this points to the
essential roles of NKATP in maintaining both the osmotic and electrochemical
gradients necessary for CSF secretion (Karimy et al., 2016). It is clear that both
NKATP and NKCC1 are important contributors to CSF secretion and regulation.
Their expression on the apical membrane ensures that there is no K+ uptake by
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CPECs from the blood (Figure 6.1). The ability of CPECs to recycle K+ at the apical
membrane is one way in which the CSF [K+] is maintained at 2.9 mM.
Under basal conditions NKCC1 is working in the net influx mode but near to
its FRP for external K+, which Russell (2000) describes as under ± 1 KJ/ mol. NKCC1
working near its FRP is normal in some cells types, such as Ehrlich ascites tumor
cells and bovine aortic endothelial cells, and is not an indication that the
cotransporter reverses transport direction (Russell, 2000). It is unlikely that [K+]CSF
would ever become low enough to support NKCC1 outward transport. Rare cases of
lower CSF [K+] do occur in some people with concomitant presentation of
hypokalemia schizophrenic-like psychiatric disorders (Hatta et al., 1999; Lam, Chau,
& Wing, 2009; Plum, 1958). However, measured CSF [K+] in psychiatric patients
does not lower more than 3% (Plum, 1958), and so is insufficient to reverse the
direction of NKCC1 transport. Therefore, we propose that in CPECs, the
cotransporter functions as a K+ absorption mechanism under basal conditions,
similar to how it functions in glia (Lu et al., 2006; Macaulay & Zeuthen, 2012). Going
back to the work of Keep and colleagues (1994), we find a few retrospective issues
in their conclusions. First, Keep et al., inhibited K-Cl cotransport with R(+)butylindazone (DOIA), a good inhibitor of KCC3 and poor inhibitor of KCC4
(Alvarez-Leefmans, 2012; Keep et al., 1994). Additionally, as our work
demonstrates, blocking NKCC1-mediated inward ion fluxes decreases [Cl-]i that
consequently reduces the amount of Cl- efflux. If CPECs rely on KCCs for K+ efflux,
then reducing the [Cl-]i would both reduce the available cell Cl- and promote WNKs,

89

3D Graph 1

∆µNKCC1 (J/mol)

10000

5000

-10000
-5000
0
5000
10000

0

-5000

-10000

0

40

2

30
20
[Na +
]i (m
M)

4

6

10

+

8
0

[K

10

)
mM
(
]o

Figure 6.2: 3D Model of the FRP of NKCC1 in CPECs
3-dimensional model of the direction of NKCC1 cotransport with respect to
intracellular [Na+] and CSF [K+]. DµNKCC1 was calculated at 310 K, with [Na+]o =
148 mM, [Cl-]o = 130 mM, [K+]o = 0 – 10 mM, [Na+]i = 0 – 50 mM, [Cl-]i = 62.1 mM,
and [K+]i = 110 mM. Modeling FRP of NKCC1 with respect to [K+]o and [Na+]i ,
and on the right is a color guide for values of DµNKCC1. The dark green areas are
when NKCC1 is working very near to its FRP. As the color becomes blue,
NKCC1 is working in the inward direction and farther away from its FRP. Areas
where the graph is yellow and red indicate that NKCC1 is working in the outward
direction and away from its FRP—acting solely in the ion secretion mode.
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and subsequently SPAK and KCC, phosphorylation that deactivates KCC K+ efflux.
Keep et al., (1994) proposed NKCC1 working near flux reversal as an explanation of
their results and those of Javaheri and Wagner (1993), who demonstrate that
intraventricular bumetanide decreases CSF secretion. We propose that the
explanation is that the constitutively active apical NKCC1 cotransporter on CPECs
functions to maintain both [Cl-]i and CWV that is necessary for normal CSF secretion
and K+ absorption. NKCC1 is likely able to sense and regulate the [K+]o through [Cl]i, similarly to the Na+/ Cl- symporter (Shekarabi et al., 2017). The low [K+]o of the
CSF promotes apical Cl- efflux by maintaining a hyperpolarized membrane potential
that is more negative than ECl (Frizzell & Hanrahan, 2012; Russell, 2000). Changes in
[K+]o lead to changes in [Cl-]i and cell volume, thereby modulating the reciprocal
phosphorylation states of WNKs, SPAK, NKCC1, KCC3, and KCC4 (Shekarabi et al.,
2017).

Future Directions

NKCC1 inhibition is currently under investigation as a treatment strategy to
reduce cytotoxic edema/ glial swelling and promote neurogenesis following brain
injuries (Begum et al., 2015; Glykys et al., 2017; Hertz & Chen, 2016; Hui et al., 2016;
Jantzie et al., 2015; Jayakumar et al., 2011; Kahle et al., 2009; Wang, Huang, He,
Ruan, & Huang, 2014; Zhang, Pu, et al., 2017). Recent research points to WNK3 and
SPAK as excellent drug targets to reduce cytotoxic edema and improve recovery
(Zhao et al., 2017). In a focal ischemic stroke model WNK3 -/-, SPAK -/-, and SPAK
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+/- mice have a > 50% reduction in lesion size and improved recovery compared to
WT mice (Zhao et al., 2017). While it appears that inhibition of NKCC1 or its
regulatory kinases improves brain injury outcome and recovery, this NKCC1
inactivation means there will be an increase in brain [K+]o that will have to be
removed. It is critical to understand how NKCC1/SPAK/WNKs inhibition in the
brain parenchyma can affect the ability of the choroid plexus to absorb excess K+
and secrete CSF. NKCC1 contributes indirectly to CSF secretion and can be a drug
target to reduce CSF production. Further work is also needed to develop a drug
capable of crossing the blood-brain and blood-CSF barriers to inhibit NKCC1 directly
or inactivate SPAK or WNKs (Zhang, Karimy, Delpire, & Kahle, 2017). By analyzing
the CSF composition and neuronal function of the NKCC1 -/- mouse, the
consequence of NKCC1 inhibition in the brain will be better understood. Also, it
would then be possible to test how NKCC1 -/- respond to increases in CSF K+ from
injury, and whether the decrease in CSF production helps with brain edema. The use
of knockout animals is increasingly more common and it is critical to have a
thorough understanding of the physiology of these animals. Preliminary work
verifies the expression of NKATPa1 and AQP1 on the apical membrane of NKCC1 -/CPECs (see Appendix A), and more work is needed to complete the screening by
including all K+ cotransporters, and performing a quantitative fluorescence intensity
analysis. Further, measuring the CPEC [K+]i using Asante Potassium Green
(TEFLabs) is necessary to complete the model of NKCC1 cotransport so that
computer models of NKCC1 transport can be used in place of animals. All
intracellular ion measurements need repeating using bicarbonate-buffered aCSF as
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control, as well as test solutions which are buffered using a combination of both
HEPES and bicarbonate.
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APPENDIX A

Pilot Experiment, Immunohistochemical verification of the
expression of NKATPa1 and AQP1 in NKCC1 -/- CPECs.
AQP1 and NKATP are both expressed on the apical membrane of CPECs (Wu
et al., 1998). Given that AQP1 is the only known water channel expressed in on the
apical membrane of CPECs, and that NKATP is the other K+ uptake mechanism with
an unusual location in this secretory epithelial cell, we decided to perform a
screening to determine whether the location of either of these membrane proteins
was changed in the NKCC1 -/- mouse. A change in the location of either AQP1 or
NKATP in the NKCC1 -/- mouse would suggest that NKCC1 somehow participates in
membrane protein sorting. The ultimate goal of this screening is to compare all of
the known ion transporters in the NKCC1 -/- mouse CP to WT controls; however, we
chose to begin with the two apical proteins that may interact with the K+-induced
changes in CWV presented above. The expression pattern of both AQP1 and NKATP
in CPECs from NKCC1 KO mice appeared to be the same as in WT, n = 1 (Figure A1).
There may be a difference the intensity of the antibody staining in the NKCC1 -/mouse, which supports further investigation to quantify the fluorescence.
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Figure A1: NKCC1 KO CPECs maintain their apical expression of
NKATPa1 and AQP1. Brain tissue obtained from male sibling WT and
NKCC1 -/- mice, postnatal age 19 days. A and B revealed the apical
expression pattern of NKATPa1 on the CP in WT (A) and NKCC1 KO (B).
In C and D, a similar apical expression pattern existed for CP from the WT
(C) and NKCC1 -/- (D).
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APPENDIX B

Animal means from the experimental data.

The following supplemental data of the individual animal statistics is
presented in the same order as it appears in the main text. Data labels show
the individual animal means ± standard deviations, with n = number of cells
from that animal.

115

WT Cross-Sectional Area Individual Animal Means ± SD
300

2

Area (µm )

250
200
150
100
50
0

KO Cross-Sectional Area Individual Animal Means ± SD
300

2

Area (µm )

250
200
150
100
50
0

Figure B1: WT and NKCC1 KO cross-sectional area animal data. Individual
statistics presented in tables on the following pages with left to right graph data
presented top to bottom in table.
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Table B1A: WT cross-sectional Areas (CSA)
Animal ID

n = cells

Mean CSA (μm2) standard deviation

12.2

9

123.4233

17.6

12.1

12

110.158

24.4

8.3

7

172.8159

21.1

6.4

6

164.9738

31.3

9.4

7

154.9809

17.9

7.3

5

142.6804

11.9

36.2

7

160.6699

21.5

40.6

15

201.1547

37.0

40.3

6

138.0045

8.8

40.1

9

169.6126

31.9

38.1

9

206.1038

42.9

38.3

7

157.5668

14.5

36.5

11

162.8289

29.2

16.4

7

167.9831

23.9

7.6

7

132.0074

11.7

2.1

8

170.7131

20.8

2.2

6

169.3866

17.0

85.6

5

117.0302

11.4

76.2

9

163.3088

21.8

75.6

7

125.1456

21.6

72.1

9

158.1353

22.9

69.3

7

171.9388

43.7

50.1

4

192.7865

18.0

48.5

16

172.1032

39.5

48.4

16

123.9412

25.4

47.4

13

168.7268

35.7

46.6

10

147.9214

24.9

44.7

9

149.7962

31.8
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42.5

16

107.9828

31.6

37.5

24

194.9336

47.6

36.6

10

129.0399

29.6

33.5

12

147.3018

36.6

33.4

17

117.2521

16.6

32.5

5

96.7644

9.6

29.2

8

134.1625

15.3

26.7

15

163.2957

19.0

4.6

5

188.6032

25.3

80.3

6

209.4189

61.0

78.2

13

194.7071

54.4

77.1

7

153.8979

15.0

75.1

30

150.6935

34.7

74.2

28

171.6309

32.4

68.6

15

143.0997

34.4

44.2

36

128.4247

29.6
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Table B1B: NKCC1 KO cross-sectional areas (CSA)
Animal ID

n = cells

Mean CSA (µm2)

standard deviation

71.1

4

132.4749

21.6

70.9

7

148.005

19.6

70.7

3

133.1665

29.4

63.4

2

191.1266

3.5

14.6

9

137.6215

33.0

62.2

11

162.6473

29.6

41.2

14

151.9135

22.2

41.4

12

159.4426

23.2

34.1

9

134.7757

16.7

33.8

9

128.9164

45.6

20.1

15

168.2091

28.9

19.2

21

125.3188

22.8

10.1

20

132.7343

17.9

4.5

11

125.2148

24.7

83.1

8

110.6741

15.1

83.4

13

125.8348

26.8

67.3

22

126.7616

35.5

47.2

21

151.5516

35.6

21.1

11

95.5485

38.3

12.2

17

157.6301

42.0

12.5

10

104.8059

17.0

6.4

15

117.6413

8.9
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Figure B2: CPEC volume response to 10 µM bumetanide
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Figure B3: CPEC volume response to 0Cl
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Figure B4: CPEC volume recovery from 0Cl.
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Figure B5: ANG-2 [Na+]i measurements
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Figure B6: MQAE [Cl-]i measurements
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Figure B7: CPEC volume response to 1 mM K+
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Figure B8: CPEC volume response to 5 mM K+
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Figure B9: CPEC volume response to 1 and 5 mM K+ in HCO3- buffered solutions.
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